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ABSTRACT
Photoacoustic (PA) imaging is a rapidly emerging non-invasive soft tissue imaging modality
which has the potential to detect tissue abnormality at early stage. Photoacoustic images map the
spatially varying optical absorption property of tissue. In multiwavelength photoacoustic
imaging, the soft tissue is imaged with different wavelengths, tuned to the absorption peaks of
the specific light absorbing tissue constituents or chromophores to obtain images with different
contrasts of the same tissue sample. From those images, spatially varying concentration of the
chromophores can be recovered. As multiwavelength PA images can provide important
physiological information related to function and molecular composition of the tissue, so they
can be used for diagnosis of cancer lesions and differentiation of malignant tumors from benign
tumors.
In this research, a number of parameters have been extracted from multiwavelength 3D PA
images of freshly excised human prostate and thyroid specimens, imaged at five different
wavelengths. Using marked histology slides as ground truths, region of interests (ROI)
corresponding to cancer, benign and normal regions have been identified in the PA images. The
extracted parameters belong to different categories namely chromophore concentration,
frequency parameters and PA image pixels and they represent different physiological and optical
properties of the tissue specimens. Statistical analysis has been performed to test whether the
extracted parameters are significantly different between cancer, benign and normal regions. A
multidimensional [29 dimensional] feature set, built with the extracted parameters from the 3D
PA images, has been divided randomly into training and testing sets. The training set has been
used to train support vector machine (SVM) and neural network (NN) classifiers while the
performance of the classifiers in differentiating different tissue pathologies have been determined
vi

by the testing dataset. Using the NN classifier, performance of parameters belonging to different
categories in differentiating malignant tissue from nonmalignant tissue has been determined. It
has been found that, among different categories, the frequency parameters performed best in
differentiating malignant from nonmalignant tissue [sensitivity and specificity with testing
dataset are 85% and 84%] while performance of all the categories combined was better than that
[sensitivity and specificity with testing dataset are 93% and 91%].
However, PA imaging cannot be used to provide the anatomical cues required to determine the
position of the detected or suspected malignant tumor region relative to familiar organ
landmarks. On the other hand, although accuracy of Ultrasound (US) imaging in detecting cancer
lesions is low, major anatomical cues like organ boundaries or presence of nearby major organs
are visible in US images. A dual mode PA and US imaging system can potentially detect as well
as localize cancer lesions with high accuracy. In this study, we have developed a novel pulse
echo US imaging system which can be easily integrated with our existing ex-vivo PA imaging
system to produce the dual mode imaging system. Here a Polyvinylidene fluoride (PVDF) film
has been used as US transmitter. To improve the anticipated low signal to noise ratio (SNR) of
the received US signal due to the low electromechanical coupling coefficient of the PVDF film,
we implemented pulse compression technique using chirp signals. Comparisons among the
different SNR values obtained with short pulse and after pulse compression with chirp signal
show a clear improvement of the SNR for the compressed pulse. The axial resolution of the
imaging system improved with increasing sweep bandwidth of input chirp signals, whereas the
lateral resolution remained almost constant. This work demonstrates the feasibility of using a
PVDF film transducer as an US transmitter and implementing pulse compression technique in an
acoustic lens focusing based imaging system.
vii
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CHAPTER 1: Introduction & Overview of the Study
1.1 Introduction:
Photoacoustic (PA) imaging is a noninvasive soft tissue imaging modality which has found a
rapid growth of interest in the last decade. Multiwavelength PA imaging has the potential to
carry out functional imaging of tissue which may lead to early detection of cancer. The low
intensity non-ionizing laser light used in PA imaging poses no health hazard, unlike the ionizing
radiation associated with some of the common medical imaging modalities like X-ray computed
tomography (CT), positron emission tomography (PET) and single photon emission computed
tomography (SPECT). PA imaging depicts the optical absorption property of the tissue. Since the
optical absorption property of a tissue changes with wavelength, using multiwavelength PA
imaging or PA spectroscopy, it is possible to carry out functional imaging of important
physiological parameters like concentration of different chromophores [light absorbing tissue
constituents] or oxygen saturation of hemoglobin etc. of the tissue [1.1]. As the name suggests,
PA imaging is a hybrid imaging modality where pulsed laser light exposes and penetrates the
tissue and sound waves are emitted by the absorbers within the tissue. PA imaging keeps some of
the specific advantages of both pure optical as well as pure ultrasound imaging. Like pure optical
imaging, the PA image contrast depends on the optical properties of the tissue and thus the PA
imaging can provide better contrast and tissue differentiation than Ultrasound (US) imaging
where the contrast comes from the difference in mechanical properties inside the tissue. At the
same time, like pure US imaging, it provides good spatial resolution at significant depth inside
the tissue in contrast with pure optical imaging where resolution degrades significantly with
increasing depth [1.2, 1.3] because of strong scattering of light in a turbid medium such as a soft
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tissue. With PA imaging, one can depict optical absorption properties of the tissue constituents
up to a few centimeters (cm) deep with sub-millimeter (mm) resolution [1.1].
Currently, the primary clinical imaging modalities used for diagnosis, management or treatment
guidance of cancer are US, X-ray CT, magnetic resonance imaging (MRI), PET and SPECT.
Although most of these technologies are well established and widely used in practice for cancer
imaging and several other applications, there are problems related to low sensitivity and
specificity for cancer detection and health hazards associated with them. As most of the
modalities still lack specificity, consequently, when a suspect lesion is visualized, biopsy is
required for confirmed diagnosis as well as prognosis. There are some other imaging modalities
like contrast enhanced ultrasound imaging (CEUS), magnetic imaging spectroscopic imaging
(MRSI) which are derivatives of these primary imaging modalities that may offer better
detection ability than the primary modalities, but issues like cost, long treatment duration and
operator dependency are associated with them.
Because of all these reasons, there is always need for a new imaging modality which will detect
cancer regions with high accuracy without posing any health hazard. PA imaging due to its
optical property based contrast and better penetration potential than pure optical imaging
modalities, is a suitable candidate to fill the requirement for a better cancer imaging modality.
Also, the fact that PA and US share the same signal receiving technology, makes it possible to
build a dual mode PA and US imaging system which can provide automatically co registered PA
and US images.
Several optical and physiological properties of a soft tissue specimen can be extracted from PA
signals generated by it and then combination of those features can be used to characterize
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particular tissue pathologies. The optical absorption property at a certain location of the tissue
actually depends on the concentration of the different types of chromophores present at that
location and absorption properties of the individual chromophores. In the spectroscopic
application of PA imaging, wavelength dependent optical absorption property of tissue, which
can be used to compute concentration of different chromophores, can be recovered from PA
images acquired at multiple wavelengths. For example, the malignant tumors are generally
expected to be hypoxic (oxygen deficient), i.e. the concentration of deoxyhemoglobin is
expected to be higher in the malignant regions than benign or normal tissue [1.1]. Different
tissue abnormalities are rich in the content of one or more specific tissue constituents or
chromophores, which to some extent become signatures of the particular tissue abnormalities.
So, the concentration of different chromophores will provide specific physiological and
molecular information about the particular tissue abnormality. For example, blood oxygen
supply plays a very critical role in angeogenesis for malignant tumors. Important functional
information about angiogenesis can be obtained from the knowledge of blood oxygen saturation
which can be calculated using the concentrations of chromophores like deoxy hemoglobin and
oxy hemoglobin [1.1]. Chromophore concentration and wavelength dependent PA image contrast
or PA pixels depend on the amplitude/intensity of the locally generated PA signal via local
optical absorption property. Frequency spectra of depth dependent one dimensional (1D) PA
signals contain significant information about the structure of PA absorbers along the depth of the
tissue specimen. By analyzing PA frequency spectrum, several metrics can be recovered which
may potentially better characterize different tissue types. This study has focused on examining
different features extracted from PA image data of tissue specimens and then testing the
significance of these extracted features using statistical analysis. Most researchers concentrate on
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visualization of physiological or optical information in the form of intensity modulated
parametric image of the object of interest using PA data and thereby detecting abnormalities
present in the object. In this study, using statistical tools, the capabilities of different features in
predicting different tissue pathologies were compared. To the best of our knowledge, this is the
first ever large scale study in which frequency domain parameters have been extracted from ex
vivo multiwavelength PA data generated by freshly excised tissue specimens from actual cancer
patients [prostate: 30 patients, 53 region of interests, thyroid: 20 patients, 41 region of interests].
The common medical imaging modalities can be divided grossly into two categories i) imaging
modalities that reveal the internal anatomical structure and ii) methods that present mapping of
physiological function [1.4]. PA imaging tends to fall more in the second category than the first.
But, in addition to detection of a particular tissue abnormality and some of its physiological
information, it is also important to localize the abnormality for making a definite treatment plan.
Although it performs poorly in detecting malignant tumors at early stage, US imaging can reveal
major anatomical cues like boundary of major organs that can be used for identifying the
location of tumor detected by PA imaging. Since the receiving technology is the same for both
PA and US imaging, it is possible to make a dual mode imaging system which shares the same
receiving set up and thus produces co-registered PA and US image of a tissue sample. A
secondary focus area of this study was to develop and test a pulse echo US imaging system,
compatible with our existing ex vivo PA imaging system.
1.2 Overview of Study
Preclinical studies with PA imaging is just beginning. Therefore there is not enough literature on
either ex vivo or in vivo studies aimed at human tissue characterization using PA data. Although
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many researchers have tried to extract features which reveal different information about tissue
specimens, very few of them tried to build a multidimensional feature space with them and then
use it to predict different tissue types. None of these researches, to the best of our knowledge,
have tried to compare the performances of features belonging to different categories. In addition
to that, as mentioned earlier, this is the first ever study with frequency domain parameters
involving a large number of excised human tissue specimens. The results of this study shine
some light on the potential of different features extracted from PA data so that in future it may be
used as a guide to initiate a large scale clinical study with human patients for testing the potential
of computer based diagnosis (CAD) with multiwavelength PA imaging. Although some thyroid
specimens were also considered for this study, the primary attention was given to PA image
analysis for prostate cancer detection.
A dual mode imaging system capable of acquiring co-registered PA and US images of the same
tissue specimen, will provide functional as well as structural information of tissue. The novel US
imaging system, developed in this study, is compatible with our existing ex vivo PA imaging
system.
The major aims of this study were


Using marked histology slides as ground truths, identification of the region of interests
(ROI) in the multiwavelength 3D PA dataset acquired on freshly excised prostate and
thyroid specimens. The PA dataset were acquired prior to the commencement of this
thesis work.



Extraction of features belonging to different tissue categories from the identified ROIs.
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Statistical analysis of the extracted features to test whether they are significantly different
between malignant, benign and normal tissue.



Building a multidimensional (29 dimensional) feature space with the extracted feature
and identification of a suitable classifier for testing the ability of the feature space to
predict malignant and nonmalignant prostate tissue.



With the same classifier previously identified, comparing the performances of the
features belonging to different categories for predicting malignant and nonmalignant
prostate tissue.



Design and characterize a novel pulse echo US imaging system compatible with our
existing PA imaging system.

Contribution of this study to the field of PA imaging for cancer detection is that it has
identified and successfully filled up the following gaps present in the said field


A large scale study for tissue characterization using PA frequency domain parameters
with PA data generated by tissue specimens of actual cancer specimens was unavailable.



To the best of our knowledge, no higher order data analysis study in which time domain
and frequency domain PA features were combined and used in a CAD system for prostate
cancer diagnosis, was available.



Performance of frequency domain PA parameters for tissue characterization was never
compared with that of time domain PA parameters.
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1.3 Organization of the Thesis
CHAPTER 2: PA Imaging and Prostate Cancer Imaging Modalities: This chapter covers a brief
introduction of PA imaging and a review of imaging modalities which are clinically available as
well as in the research stage for prostate cancer imaging.
CHAPTER 3: Preliminary Works: This chapter covers the description of ex vivo PA imaging
system, PA system characterization, experimental protocol for acquiring ex vivo PA images and
ROI selection using ground truths.
CHAPTER 4: Feature Extraction from Time Domain PA Signal: This chapter covers feature
extraction from multiwavelength time domain PA data generated by the excised tissue
specimens. It contains the results of statistical analysis, performed to test whether the features are
significantly different among cancer, benign and normal tissue.
CHAPTER 5: Feature Extraction from Frequency Domain PA Signal: This chapter covers
feature extraction from frequency domain multiwavelength PA data generated by the excised
tissue specimens and corresponding statistical analysis of the extracted features belonging to
different tissue categories. It also contains modeling of time dependent 1D PA signals and the
corresponding frequency spectra generated by PA absorbers of different shapes.
CHAPTER 6: Computer Aided Diagnosis Using Extracted PA Features: This chapter covers the
formation of a multidimensional feature space using the extracted features and the performances
of different classifiers using the feature set to predict malignant and nonmalignant tissue. It also
contains the comparison of performances of features belonging to different categories for
predicting malignant and nonmalignant tissue.

7

CHAPTER 7: Novel US Imaging System: This chapter covers the development and
characterization of the pulse echo US imaging compatible with our existing PA imaging system.
CHAPTER 8: Discussions, Conclusions & Future work: This chapter covers the discussions,
conclusions of this study along with the possible future works.
APPENDICES: The Appendices contain some additional works performed and results obtained.
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CHAPTER 2: PA Imaging and Prostate Cancer Imaging Modalities
2.1 PA Imaging
The generation of ultrasound waves by a light absorbing material following the absorption of the
modulated light, usually pulsed laser light on a nanosecond timescale, is known as photoacoustic
effect. The absorbed light energy produces localized heating which in turn produces a
temperature rise, well below the amount of rise required to produce physical damage or phase
change inside the object. This temperature increment gives rise to an initial pressure increase due
to rapid thermal expansion. The pressure increase subsequently relaxes generating broadband
low amplitude ultrasound waves. These ultrasound waves or better known as photoacoustic
waves, emitted from the object, are captured by ultrasound transducers in different
configurations depending upon the mode of imaging, to produce a sequence of A-line signals
[2.1]. An A-line signal is simply the display of the time dependent response of the transducer
generated by the ultrasound wave [2.2]. The A-line signals are suitably processed and combined
to produce the 2D (two dimensional) photoacoustic images of the materials.
The spectrum of the emitted acoustic waves can extend to several tens or even hundreds of
Megahertz, depending upon the shape and structures of the light absorbers. Frequency dependent
acoustic attenuation of the soft tissue limits the maximum frequency content of the emitted US
wave. Due to frequency dependent attenuation, a tradeoff exists between the spatial resolution
and the penetration depth. The higher the peak frequency of the emitted PA signal, the better will
be the lateral as well as axial resolutions but the penetration depth will be poorer [2.3]. Some
other factors, like detector bandwidth, detection configuration and detection area aperture limit
the spatial resolution of the PA images. The penetration depth of the PA images are much less
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than that of conventional pulse echo US images, as for pulse echo US imaging, localization can
be achieved in both the transmit and the receiving beam whereas for the PA imaging, localization
can be achieved only in the receiving beam and within 1 mm of the transmit beam. For pulse
echo US imaging, the focal peak pressures of the US wave can be orders of magnitude higher
than that of the US waves generated in case of PA imaging [2.1].
2.2 Prostate Cancer Imaging Modalities
Prostate cancer is the second leading cause of cancer induced death in America, preceded by
lung cancer. The American cancer society has estimated that, in the United States for the year
2014, about 233,000 new cases of prostate cancer will be diagnosed with about 29,480 deaths
[2.4]. From 2006 - 2010, the annual incidence of prostate cancer was 152 per 100,000 [2.5].
Typical prostate cancer screening procedures like digital rectal examinations (DRE) and
prostate specific antigen (PSA) level checking have increased the percentage of early
diagnosis (organ confined lower grade prostate cancer) of prostate cancer significantly [2.6,
2.7]. There are certain challenges associated with early diagnosis of prostate cancer. Some
of those challenges are related to selection of clinically relevant tumors among all types of
detected tumors, treatment selection and long term consequences of specific treatment
strategies [2.8, 2.9]. As the different medical imaging modalities are evolving rapidly,
prostate cancer imaging is becoming increasingly important as it can assist in diagnosis,
clinical assessment and treatment planning of prostate cancer. Following is a brief
discussion about the roles of different conventional medical imaging modalities for
detection and management of prostate cancer.
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2.2.1 Ultrasound Imaging:
Persisting elevated Prostate Specific Antigen (PSA) levels and/or suspicious lesion felt on
Digital Rectal Examination (DRE) leads to guided needle biopsy for prostate cancer diagnosis.
Grayscale transrectal ultrasound (TRUS) imaging is the most widely used guidance tool
associated with needle biopsy. Cancer regions are typically expected to appear hypoechoic
in the US images although many prostate cancer regions appear isoechoic in TRUS images.
The facts that almost half of the prostate cancer regions remain invisible in the US images
and some of the commonly occurring benign prostate pathologies have similar appearances as
cancer regions reduce the effectiveness of TRUS imaging as a diagnostic tool [2.10]. The
sensitivity and specificity of TRUS in detecting prostate cancers is reported to be 41% and 81%
respectively while the positive predictive value (PPV) and the negative predictive value (NPV)
are found to be 52.7% and 72% respectively, with an accuracy of 67% [2.8]. Consequently
TRUS guided needle biopsies generally are not targeted but systematic multi-core in nature that
try to sample the entire gland using one of the many popular schemes [2.11]. Typically 5 to 12
core samples are taken from various regions of the gland, but due to sampling errors, there is
more than 20% chance of misleading the diagnosis [2.11, 2.12]. Although, TRUS imaging may
not be very effective in detecting cancer lesions, it can be effectively used to measure the shape
and volume of the prostate gland. Volume of the prostate gland can be used to measure PSA
density [serum PSA level in nanograms/milliliter per unit volume of prostate in cubic
centimeters] and grade of the cancer. TRUS has wide use in therapy also as it is used for guiding
and directing the treatment in brachytherapy, cryotherapy and focal ablation of prostate tumors.
Because of its wide availability and low cost, TRUS plays a major role in prostate cancer
diagnosis and management [2.9]. Exploiting the observation that neovascularization is associated
12

with prostate tumor growth, CEUS attempts to increase the sensitivity of cancer lesion detection
by visualizing passage of injected gas encapsulating spheres or microbubbles in the bloodstream
through the prostate. Harmonic imaging technology can be used alongwith CEUS imaging to
potentially reduce the number of sampled cores in systematic biopsy [2.10]. Elastography, where
rigidity and elastic property of prostate is measured and cancer lesions are identified using the
measure of firmness, is another approach of ultrasound imaging for prostate cancer diagnosis
[2.8].
2.2.2 Magnetic Resonance Imaging
MRI can also be used for prostate cancer detection. In T2-weighted MR imaging, cancer
lesions are typically expected to generate low signal regions in the background of high
signal regions corresponding to normal tissue, whereas in T1 images homogeneous signal
intensity is generated throughout the prostate gland making detection of the cancer lesions
impossible. Similarity in appearance of some of the benign prostate pathologies with
prostate tumor in T2 weighted MR images lowers the specificity of MR I [2.8]. There are
some suggestions of using MR imaging for prostate cancer screening, but that has not been
implemented widely due to its high cost and low specificity [2.8]. The idea of using MRI for
needle biopsy guidance is under consideration where the major obstacles are its high cost,
procedural duration and limited reach, specifically towards the base of the prostate [2.8,
2.13]. Endorectal MR imaging can be used efficiently for staging of prostate cancer
although there are some concerns about inter-observer variability [2.9]. Spectroscopic MR
imaging, which measures the concentrations of different metabolites in tissue and thus can
differentiate a cancer region from its surrounding normal tissue by the difference of the
concentration of specific metabolites, can increase the specificity of MR I [2.9].
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Spectroscopic MRI can be potentially used to assess tumor aggression, measure recurrent
cancers and combined use of MR with spectroscopic MRI can be used for guided needle
biopsy [2.8]. Dynamic contrast enhanced MRI can potentially detect angiogenesis at cancer
lesion and thereby increase the accuracy of prostate cancer detection [2.9]. Diffusion
weighted imaging can be a potential tool to detect recurrent prostate cancer by measuring
the diffusion coefficient of water in intracellular and extracellular spaces [ 2.8, 2.9]. Using
lymphotrophic superparamagnetic nanoparticles as contrast agents, MR images can
potentially detect metastasis [2.8]. Multiparametric MRI which combines more than one of
the MR based techniques mentioned before, can potentially increase the accuracy for
prostate cancer diagnosis and staging [12].
2.2.3 X-ray Computed Tomography (X-ray CT) Imaging
Computed tomography has very limited application in prostate cancer detection or staging at
the primary level. It is generally used for staging of prostate cancer in the patients who have
suspected metastatis [2.8].
2.2.4 Positron Emission Tomography
The primary motivation of using positron emission tomography (PET) imaging to detect
prostate cancer is that prostate cancer, because of its high metabolic rate and glucose
consumption through glycotic pathway, will show higher uptake of glucose analog than
normal prostate. Primarily, PET studies use fluorodeoxyglucose (FDG) as the radiolabelled
analogue of glucose to detect cancer lesions by measuring the metabolic rate of tiss ue [2.8].
But various studies have shown disappointing results concerning the sensitivity of FDG PET
[2.15]. In addition to that, one group has shown that FDG PET could not differentiate
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between prostate cancer and benign prostatic hypertrophy [2.13]. Studies with other types of
tracers like radiolabelled amino acids which will detect lesions with high protein synthesis,
are being pursued [2.8]. Combination of PET and CT has the capability of identifying the
location of prostate tumor in prostate bed [2.9].
Among the different imaging modalities discussed above, TRUS is expected to remain the
primary imaging tool for screening and diagnosis of prostate cancer because of its wide
availability, relatively low cost, easy to use nature as well as its role in guided needle biopsy
[2.9, 2.14]. But due to its low sensitivity and specificity, there is considerable diagnostic
uncertainty associated with TRUS. Even when it is used for guiding needle biopsy, due to
its limited ability in detecting and localizing the cancer lesions, the complete gl and has to be
sampled systematically. The sensitivity of the procedure increases with the number of
sampling, but the procedure become very painful after a certain number of samples [2.9]. As
US does not have any prognostic value, so patients at risk of having prostate cancer have to
be under active surveillance and undergo repeat biopsies even after negative initial biopsy.
As a result, patients have to undergo tremendous anxiety, physical discomfort and additional
burden of cost. As mentioned earlier, there have been attempts to improve the accuracy of
TRUS imaging by introducing several US based methods like CEUS, elastography etc., but
they have not improved the accuracy significantly [2.16 – 2.19]. Among the other available
imaging modalities, multiparameteric MR imaging seems to be the most suitable choice for
achieving high diagnostic accuracy. But due to the high cost and long procedural duration, it
cannot be performed on every patient at risk of prostate cancer. So, there is a need of a new
imaging modality which will have high sensitivity as well as specificity for prostate cancer
diagnosis. As TRUS is expected to remain the major imaging modality, so any new imaging
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modality which can be integrated with TRUS seems to be an extremely suitable choice not
only for effective detection and localization of prostate cancer but also for proving guidance
to optimized needle biopsy.
2.3 Photoacoustic Imaging for Prostate Cancer
Yasseen et al. acquired in vivo PA and US images of a canine prostate containing induced
blood rich lesion and observed that the induced lesion was visible in the PA image while US
image did not show it [2.20]. In a similar study, Wang et al. acquired multiple in vivo PA
and US images of pseudo lesion contained canine prostate and they observed the mean PA
intensity of the pseudo lesion increased linearly with the volume of the total blood injected
in the pseudo lesion [2.21]. Baur et al. performed coregistered 3D PA and US imaging and
PA spectroscopy on mice, injected with PC-3 prostate tumor cells in a window chamber, to
monitor tumor size and vasculature [2.22]. In a similar study, Olafsson et al. investigated
tumor progression within mice in window chamber by performing contrast enhanced PA
imaging with the use of gold nanorods [2.23]. Brachytherapy is an important option for
prostate cancer treatment. It is a minimally invasive surgical procedure in which multiple
seeds or grain sized radioactive sources are placed permanently inside the prostate so that
their combined radiation is directed to destroy cancerous tissue [2.24]. For accurate
positioning of the seeds at desired sites, real time guidance and position feedback by a
suitable imaging modality is required. Although, TRUS is the common imaging modality
used for these purposes, due to its poor imaging quality, the position feedback is not
sufficiently accurate. As metallic brachytherapy seeds have high optical absorption
coefficient compared to that of soft tissue, so PA imaging is expected to provide high
intensity regions corresponding to the seeds. So, a dual mode PA and US imaging modality
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can be very suitable for brachytherapy seed plant. Using a tissue phantom, Harrison and
Zemp observed that at 1064 nm wavelength, PA imaging can detect brachytherapy seeds
uniquely up to 5 cm deep inside the soft tissue with 26.5 dB contrast to noise ratio while the
input laser fluence was maintained at ANSI limit for human exposure [ 2.25]. Su et al.
acquired PA and US images of excised bovine tissue with seeds implanted in it and they
found that PA images yield improved contrast ranging from 2.7 dB to 27.9 dB over US
imaging for imaging depths ranging from 4 cm to 13 cm while the longer axis of the seeds
was parallel to US transducer face [2.26]. Kuo et al. performed ex vivo PA imaging of
excised canine prostate with multiple brachytherapy seeds implanted in it [ 2.24].
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CHAPTER 3: Characterization of the Pre Existing PA Imaging System and ROI Selection
3.1 Ex vivo PA Imaging
3.1.1 Literature Review
Depending upon the detection configuration, primarily there are two different PA imaging
modes, namely
A. Photoacoustic tomography (PAT).
B. Photoacoustic microscopy (PAM).
Ideally, to form an image of a point absorber, the entire portion of the emitted PA wave
generated by the object needs to be acquired by the US transducer. In PAT, this is accomplished
by acquiring the PA wave either with a specially designed transducer array where the array
elements are arranged along a particular geometry or with a single element transducer,
mechanically scanning around a particular geometry depending upon the shape of the object
while the complete object is irradiated by a large diameter diffused laser light. Then a suitable
beamforming algorithm is employed to reconstruct the required two dimensional (2D) or three
dimensional (3D) PA images from the acquired PA signals [3.1 – 3.4]. In PAM, either a focused
transducer is mechanically scanned to collect the emitted PA wave or a tightly focused laser
beam is used to scan the object where the transducer remains stationary. The required PA images
are formed directly from the set of PA signals without using any kind of beamforming
algorithms [3.5 – 3.11]. PAM can be further divided into two categories depending upon the PA
image acquisition setup. If the focused transducer is used to scan the object i.e. if the point
spread function of the transducer determines the spatial resolution then the corresponding PAM
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mode is known as Acoustic resolution photoacoustic microscopy (AR-PAM) [3.6 – 3.9]. If the
focused laser beam is used to scan the object i.e. if the lateral resolution is determined by the
diffraction limited tightly focused laser beam width, then the corresponding imaging mode is
known as Optical resolution photoacoustic microscopy (OR-PAM) [3.10 – 3.11]. The primary
advantage of using a focused transducer as used in the conventional PAM mode, is that no
beamforming algorithm or electronic focusing is required and consequently there are no errors in
the reconstructed image due to spatial and temporal sampling of the signal. However one
disadvantage with a focused transducer is that at one point of time, only one point in the tissue
sample will be in focus since the focusing element is typically placed on top of the single
element transducer and thus a significant amount of time will be required to scan an object of
significant dimension.
3.1.2 Development of the Ex vivo PA Imaging System [Prior Work]
Prior to the commencement of the present study, the ex vivo PA imaging acquisition system was
developed in our laboratory. Although it was not a part of the present study, for the sake of
understanding and completeness, the PA imaging system has been described in a concise way.
An acoustic lens based setup has been employed in our ex vivo PA imaging setup. Here, the
focusing element i.e. the acoustic lens is separately placed from the transducer and thus at a
certain time instant instead of a single point, a whole plane is in focus. The acoustic lens is
actually placed in between the tissue and the transducer and creates a focused image of the
object/tissue on the image plane i.e. on the transducer. Thus, in principle, this set up can acquire
the focused image of the object plane/tissue surface almost instantaneously with a 2D array, just
like a conventional optical camera. The object plane here corresponds to the coronal plane in the
tissue. It has been found that the difference in travel time from different points on the object
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plane to their corresponding conjugate points on the image plane is usually less than the
difference of time between two consecutive zero crossing points in the time dependent PA
signal. Therefore the entire image plane is in focus and is conjugate to the corresponding object
plane [3.12].
Figure 3.1 shows the ex vivo PA imaging system developed in our laboratory.

Figure 3.1: Ex-vivo PA imaging system (A) Acoustic lens focusing based PA image acquisition
approach (B) The actual PA imaging probe with tissue sample holder.
Transillumination geometry, in which the light source and US transducer are placed on the
opposite sides of the tissue specimen, was employed in this PA imaging system. Figure 3.1A
shows the concept behind the acoustic lens based focusing approach. Once the prostate specimen
was illuminated with pulse laser beam, the light absorbing tissue constituents absorbed laser light
and emitted PA waves which travelled to all directions. The portions of the PA waves travelling
towards the cylinder containing the acoustic lens and transducer array, were focused by the
acoustic lens on the transducer array. To achieve unit magnification, the object distance i.e. the
distance between the acoustic lens and the object plane and the image distance i.e. distance
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between the acoustic lens and the transducer array were made equal to twice the focal length of
the acoustic lens. Figure 3.1B shows the actual ex vivo PA imaging setup developed in our
laboratory. The adjustable laser arm holds the fiber bundle which delivers the pulsed laser light
from the tunable laser (wavelength: 700 - 1000 nm, pulse repetition frequency: 10 Hz, pulse
duration: 5ns (nanosecond), EKSPLA, Vilnius, Lithuania) on the tissue sample holder. The
sample holder can accommodate tissue samples up to 4 cm thick. During PA imaging, the
sample holder and the water sealed cylinder containing the custom designed acoustic lens (focal
length: 39.8 mm, diameter 32 mm) and the 32 element 1D US transducer array (OLYMPUS
NDT, State College, PA,USA) were both filled with saline water. Center frequency and pitch of
the transducer array are 5 MHz and 0.7 mm. The fiber bundle carrying arm and the cylindrical
container are attached with each other and together they will be referred as PA camera from now
on. The depth of field of the lens is approximately +/- 0.5 cm around the focal plane. Figure 3.1A
shows that if we receive the signal at each of the 32 elements of the 1D transducer array over a
sufficiently long time gate and then map the corresponding arrival times to distances, then we
will get 32 adjacent 1D radio frequency (RF) PA signals or A-line PA signals, which can be
further processed to produce a focused B-scan image representing a particular sagittal plane. To
acquire PA image of an excised tissue specimen, the specimen was held stationary by the sample
holder and using dual axis linear stepper motors, the PA camera raster scanned the specimen to
acquire a set of PA A-line signals over a long time gate. A C-scan image i.e. image representing
particular transverse planes is formed by applying a narrow time gate to the whole set of the Aline PA signals. The transducer array is connected to a custom designed data acquisition (DAQ)
system (APCON, Rochester, NY, USA) to digitize and store the PA radio frequency (RF) signals
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in the computer. We use our own Matlab (v2012a, Mathworks Inc., Natick, MA, USA) based
software to form different C-scan or B-scan images from the stored PA dataset.
3.1.3 Multiwavelength PA Imaging of Excised Human Tissue Specimens [Prior work]
Photoacoustic imaging at five different wavelengths was performed on the freshly excised
human prostate and thyroid specimens. Imaging as well as data collection was done prior to the
present study. For the sake of completeness, the experimental protocol is described here. The
prostate specimens were collected from patients who underwent prostatectomy for biopsy
confirmed prostate cancer. The excised thyroid specimens were collected from patients with
suspected thyroid lesions after they underwent thyroidectomy. Before proceeding with the
studies, approval from Institutional Review Board (IRB) was obtained along with consent from
each patient. The studies were in compliance with Health Insurance Portability and
Accountability Act.
Experimental Protocol for ex vivo imaging of excised tissue specimens:

Figure 3.2: Experimental protocol for Ex vivo PA imaging of excised tissue samples.
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Figure 3.2 shows the experimental protocol, used for acquiring multiwavelength PA images of
excised human tissue specimens. Immediately after surgery, the excised prostate or thyroid
specimen was sent to the surgical pathology laboratory where it was inked and cut into thin
sections (2-5 mm thick) by a pathologist. One such section with a grossly visible nodule was
selected, immersed in normal saline to prevent dryness and sent to our laboratory where we
acquired PA images of it at five different wavelengths. Once PA imaging was done, the tissue
specimen was returned to the surgical pathology laboratory for histopathology. The complete
process of sectioning the excised specimen, acquiring the PA images and then returning it to the
surgical pathology laboratory was finished within 1 hour after surgery. It was verified and
approved by the pathologist to ensure that the histopathology procedure of the specimen was not
compromised. The laser intensity on the excised prostate specimen was maintained around 5 mJ
(milli Joules)/cm2 which is well below the safe human exposure limit according to American
National Standards Institute guidelines [3.13].
Choice of wavelengths:
The five wavelengths, at which the PA images were acquired, were chosen in such a way that
each wavelength corresponds to the peak of the absorption spectrum of a particular chromophore
in the 700 nm – 1000 nm wavelength range. Chromophores are the light absorbing tissue
constituents. Following are the pairs of selected wavelength and chromophore with peak
absorption at the selected wavelength: 760 nm – deoxyhemoglobin (dHb), 850 nm –
oxyhemoglobin (HbO2), 930 nm – lipid and 970 nm – water [3.14 - 3.16]. The additional
wavelength 800 nm was chosen as at this wavelength, absorption coefficient of both dHb and
HbO2 are equal [3.15, 3.16].
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3.2 PA Image Formation and ROI Selection
3.2.1 PA Image Formation
The entire cross sectional surface of the tissue sample is raster scanned by the PA camera to
acquire a set of A-line PA signals, each element of the transducer array generating one A-line
signal. An A-line signal contains the time dependent one dimensional (1D) RF PA signals
plotted against time/ Z axis. Since the acoustic wave has finite velocity, the arrival times of the
A-line signal can be mapped to the depth of the absorbers along Z axis. The instant when the
laser starts firing the pulses, is time t = 0. The PA signals acquired by all the 32 channels of the
transducer array at each position of PA camera are transmitted simultaneously to the custom
made DAQ unit which contains a variable gain amplifier and digitizer to suitably amplify and
digitize/sample the acquired data. A grayscale plot of the adjacent envelope detected A-line PA
signals in the XZ plane produces the 2D B-mode [Brightness - mode] image. The entire set of Aline signals forms 3D PA signal, generated by the tissue sample. A constant depth C-mode image
or cross-sectional image is produced by applying a small time gate to the entire set of envelope
detected PA A-line signals and creating brightness modulated display by taking the mean of the
signals along Z axis/ time axis within the time gate.
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Figure 3.3: (A) A typical excised human prostate tissue specimen (b) C-mode PA image of the
prostate tissue sample, taken at 760 nm wavelength.
Figure 3.3A shows a photograph of the prostate tissue sample taken with a conventional camera
as the sample was held in the sample holder and ready to get raster-scanned for obtaining the PA
images. Figure 3.3B shows the C-scan PA image of the prostate sample.
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Figure 3.4: (A) prostate tissue sample (B) A-line PA signal corresponding to highlighted grid
point or pixel in red in the prostate sample, the blue line represents the RF signal while the red
line represents the envelope detected RF signal (c) PA B-mode image corresponding to the array
of pixels marked by the red rectangle in the image of the prostate sample.
Figure 3.4 shows the raster scan geometry of the prostate tissue sample. It also shows how the
PA A-line signals and B-mode PA images are generated. The object plane/tissue surface can be
imagined as a grid of square elements due to the finite size of the transducer elements. Tissue
under each square element generates an A-line PA signal and envelope detected brightness
modulated plot of the adjacent A-line signals of each column of the grid in the XZ plane
generates a B-mode PA image.
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Figure 3.5: C-mode image formation (A) PA A-line signal corresponding to a particular point on
the tissue sample, (B) B-mode PA image in the XZ plane, (C) C-mode PA image in the XY plane
generated by applying the small time gate, shown by the dashed black rectangle in 3.5A applied
to the complete set of envelope detected A-line signals.
Figure 3.5 shows how the 2D C-mode images representing different cross sectional planes have
been generated by time-gating the A-line signals. Each A-line signal has been sampled with a
sampling frequency 30 MHz, as the maximum detected frequency cannot go over 15MHz. The
A-line signals have been studied carefully. The length of each A-line signal is around 133μs, the
first 100μs length of each A-line signal have been ignored as those data come from the
cylindrical container of the PA camera. Out of the rest i.e. 33μs long data, only around 2μs to 4μs
long data were generated by 3mm to 5mm thick tissue samples. The portion of the A-line signals
generated by the tissue samples is identified closely inspecting the PA A-line signals. As
mentioned earlier, for generating a C-mode image from the 3D dataset a small but suitable timegate is required. The center of the time gate is chosen as one of the peaks of the tissue generated
portion of a significant A-line signal. The width of the time gate is generally short, around 0.2μs,
so that the different attributes of the tissue sample at different depths can be captured by separate
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C-mode images formed by applying separate time gates to the tissue generated PA A-line
signals. The C-mode PA image is generated by creating a brightness modulated display with the
mean of the envelope detected time gated portions of the PA A-line signals along Z axis and.
3.2.2 ROI selection
Using marked histology images as ground truth, ROI corresponding to cancer, normal and
benign tissue were selected in this study. The histopathologist performed histopathology on each
excised specimen, imaged in our laboratory. The digital images of the marked histology slides
were co registered with the C-scan PA images of the specimens to identify the ROIs
corresponding to different tissue pathologies. Generally the PA images do not show any
prominent features/cues which can help to register the PA images with the digital histology
slides. As mentioned previously, before slicing the original excised tissue specimen into thin
sections, the pathologist inked it. This ink generated pretty high PA signal at all the five
wavelengths. The high signal generated by the ink defined the boundary of the specimen in its
PA image and that boundary guided us in registering the PA images with the histopathology
images. The registration between the 2D C-scan PA images with the digital histology images
were achieved manually. We tried boundary extraction and projective geometry based automatic
registration, but that was not very successful for all of the specimens. The form and depth of high
intensity boundary produced by the ink signal were not consistent for all the specimens. Many
large specimens were divided into smaller sections before histology which required stitching of
histology images of tissue portions before registration. Because of these reasons and the huge
difference in resolution between the PA images [64 x 45] with the digital histology images [512
x 1024], the automatic registration was not successful. The manual registration was a two step
process. In the first step, the digital histology image was registered with the digital image of the
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tissue specimen, captured in our laboratory before acquiring PA images. In the next step, the
digital image of the tissue specimen was registered with the C-scan 2D PA image. Thus ROIs in
the PA images corresponding to the marked regions in the digital histology images can be
identified.

Figure 3.6: Digital image of a thyroid tissue specimen containing malignant region (B) Marked
digital histology image, malignant region marked by the blue circle (C) Corresponding C mode
PA image, a ROI in the center of the malignant region is marked by the white circle.
Figure 3.6A shows the digital image of a particular thyroid tissue specimen and Figure 3.6B and
3.6C show the corresponding marked digital histology image and the C-scan PA image. The
malignant region is marked by the blue circle in 3.6B while a ROI corresponding to the
malignant region is marked by the white circle in Figure 3.6C. To make the process of manual
registration accurate, we built a graphical user interface (GUI) tool using matlab. The digital
images of the tissue specimens were captured placing two small scales on top and left of the
specimen. Using these scales and the GUI, we measured the dimensions of the tissue specimen.
We assumed the histology section was of similar dimensions. Again using the GUI, we measured
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the dimensions and position of the ROI, relative to the boundary of the histology section. Next
we identified the boundary produced by the high intensity ink signal in the C-scan PA image and
selected a ROI using the dimension and relative position information retrieved from the
histology image.

Figure 3.7: Matlab based GUI for ROI selection the PA images. The three images in Figure
3.6A, 3.6B and 3.6C are shown in the three panes.
Once a ROI was identified in a C-scan image the same ROI was applied to the 3D PA dataset to
select the PA A-line signals corresponding to particular tissue pathology.
3.3 Characterization of the Ex vivo PA Imaging System
Detail characterization of the ex vivo PA imaging system was a part of this study. For
characterizing the system, we measured 2D point spread function (PSF) of the system in the XZ
plane, sensitivity of the system at different depths inside soft tissue and variation of 2D PSF with
distance from the probe.
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3.3.1 Point spread function in X-Z plane [B-scan image plane]:
PSF of our ex vivo imaging system in the XZ plane was measured using a 0.2 mm diameter lead
pencil as the target in a water bath. The lead pencil was placed perpendicular to the axis of the
transducer array of the PA imaging probe so that it behaved like a point source in the XZ plane.

Figure 3.8: Experimental setup for measuring PSF in the XZ plane.
Figure 3.8 shows the experimental setup for measuring the PSF of our ex vivo PA imaging
probe. Here the lead pencil was placed in a water bath and the laser light illuminated the lead
pencil from side without any fiber bundle. The probe was placed directly on top of the lead
pencil in such a way that the pencil remained at right angle to the X axis or azimuth of the
transducer array and the center of the probe saw the pencil. The distance between the face of the
probe and the lead pencil was kept very small [~ 5 mm], so that the pencil could maintain an
object distance approximately equal to the twice the focal length of the acoustic lens from the
lens. Once the laser illuminated the pencil, it emitted PA wave which was focused by the
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acoustic lens on the transducer array. To acquire PA data, 800 nm wavelength of the tunable
laser was used.
Results:

Figure 3.9 (A) 2D PSF of the ex vivo PA imaging probe in XZ plane (B) Lateral cut (along
azimuthal/X axis) of the 2D PSF in A (C) Axial cut (along time/Z axis) of the 2D PSF in A. The
pair of red lines in Figure 3.9B and 3.9C show the Full width half maximum (FWHM) along the
lateral and axial direction. The lateral FWHM is 2.45 mm while the axial FWHM is 0.34 mm.
Figure 3.9 shows the 2D PSF of the ex vivo PA imaging probe in XZ plane. FWHM of the 2D
PSF along lateral and axial directions are 2.45 mm and 0.34 mm respectively.
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Figure 3.10: PA A-line signal and B-scan image with transducer array position (A) PA A-line
signal acquired by the central element of the 32 element transducer array (B) B-scan PA image
formed by envelope detecting the A-lines acquired by transducer array.
Figure 3.10 shows the PA A-line signal and B-scan PA image generated by the lead pencil.
3.3.2 Variation of 2D PSF with distance from PA Probe
As mentioned in Section 3.3.1, during the measurement of 2D PSF of the PA imaging system,
the distance between the PA probe and the target (lead pencil) was maintained around 5 mm so
that the object distance for the acoustic lens was maintained approximately equal to twice the
focal length of the lens. Maintaining the same setup as shown in Figure 3.8, we also measured
different 2D PSFs at different distances between the lead pencil and the PA probe. The distance
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between the PA probe and the lead pencil was changed with the help of a linear stepper motor
within a range of 3 mm to 50 mm.

Figure 3.11: PSF variation with distance between the target and PA probe (A) Variation of lateral
FWHM with probe distance from target (B) Variation of axial FWHM with probe distance from
target.
Figure 3.11 shows the variation of FWHM along lateral as well as axial direction with the probe
distance from target. From Figure 3.11A, it can be seen that the lateral FWHM seemed to change
slightly with distance while Figure 3.11B shows that the axial FWHM remained uniform at all
probe distances.
3.3.3 Sensitivity measurement:
To measure the sensitivity of the our experimental setup at varying depths inside soft tissue, we
acquired PA images of chicken tissue with 0.7 mm diameter lead pencil inserted in it and
measured the ratio of the pencil generated PA signal to background signal.
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Figure 3.12: Experimental setup for measuring sensitivity at different depths inside the chicken
tissue.
Figure 3.12 shows the experimental setup for measuring sensitivity at different depths inside
chicken breast tissue. The chicken breast slab with a lead pencil inserted in it was placed in such
a way that the pencil was at right angle to the azimuth of the transducer array and the center of
the probe saw the lead pencil. The laser illuminated the chicken tissue with the lead pencil from
side. The chicken tissue with lead pencil was placed in a water bath. We inserted the same lead
pencil at different positions of the chicken breast slab such that the laser light had to travel
different distances inside the tissue before it reached the lead pencil. Once inside the tissue, light
is expected to be attenuated significantly due to absorption and significant scattering, caused by
the tissue. The aim of the experiment was to determine, how deep our experimental setup could
image inside the soft tissue. The laser wavelength used for his experiment was 800 nm and the
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input laser intensity was around 30 mJ/cm2. For this experiment, the depth signifies various
positions along X axis inside the tissue.
Results:

Figure 3.13: PA images of the lead pencil inserted at 0.5 cm depth (A) B-scan PA image (B) Aline PA signal acquired by the center element of the transducer.
Figure 3.13 shows the B-scan and A-line PA images of the lead pencil inserted at 0.5 deep inside
the chicken tissue. The signal to background ratio, computed using Figure 3.13A is 21.3
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Figure 3.14: PA images of the lead pencil inserted at 2 cm depth (A) B-scan PA image (B) Aline PA signal acquired by the center element of the transducer.
Figure 3.14 shows the B-scan and A-line PA images of the lead pencil inserted at 2cm deep
inside the chicken tissue. The signal to background ratio, computed using Figure 3.14 is 2.6.

Figure 3.15: Sensitivity at different depths inside the chicken tissue.
37

Figure 3.15 shows a plot of signal to background ratio or sensitivity at different depths inside the
chicken tissue. We can see that the sensitivity is reduced significantly at 2 cm depth. Beyond 2
cm, we could not record any legible signal. As the input laser intensity for this experiment was
on higher side, so for tissue imaging we can conclude that our experimental setup will be able to
image up to 1.5 cm deep inside the tissue.
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CHAPTER 4: Feature Extraction from Time Domain PA Signal
The aim of PA imaging is to gain important information related to physiology and composition
of soft tissue and on the basis of those information, detect particular tissue abnormalities. In this
study, we extracted different types of features from the ex-vivo PA images of human prostate
and thyroid specimens. Using marked histology images as ground truth, region of interests (ROI)
corresponding to malignant, benign and normal tissue were identified in the PA data and then the
features were extracted from the selected ROIs. Statistical analysis with the extracted features
was performed to test whether they were significantly different between different tissue
pathologies. We used time domain PA signals as well as frequency spectrum of the RF PA
signals to extract different features. The time domain features were extracted from C scan 2D PA
grayscale images which were formed using mean of the envelope detected PA signal amplitudes
acquired over a small time gate. The time domain PA features belong to two primary categories
A. Multiwavelength PA pixels.
B. Chromophore concentrations.
Before going into details of the extracted time domain PA features, it is important to understand
how the PA signal amplitudes depend on the optical properties of the soft tissue.
4.1 Optical Properties of Soft Tissue
The interaction of light with the turbid tissue media can be classified in general into two
categories, namely scattering and absorption. When the medium only redistributes the incoming
light along different directions without altering it otherwise, then scattering takes place. But if
the energy of an incoming photon matches up with one of the excited states of a constituent atom
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of the medium, then the atom absorbs the photon, goes up to the higher energy level and then
releases the excitation energy in the form of thermal energy. So in this process the incoming light
energy is lost to some other form of energy. This is known as absorption. For a purely absorbing
homogeneous medium [in absence of scattering or very low scattering], the absorption process is
governed by the Lambert-Beer‘s law given by Equation 4.1[4.1]
I z  I 0 exp( a z )

4.1

Here, Iz is the light intensity at depth z, I0 is the input light intensity and μa is the optical
absorption coefficient of the medium. Now, if the medium possesses scattering properties, then
under the condition of μa > μs the Lambert-Beer law will be modified as Equation 4.2 [4.2]
I z  I 0 exp( t z ) , t   a   s

4.2

Here μt and μs are the total attenuation coefficient and the optical scattering coefficient of the
medium.
For biological tissues, in the Near Infra Red (NIR) wavelength region, huge scattering of light
takes place during the propagation of light through the medium. In fact scattering is the main
source of attenuation of light inside the tissue. So, after a certain depth z, when z >> 1/μ t,
diffusion approximation can be applied to the radiative transfer Equation describing the
distribution of light in the tissue. Diffusion approximation is applicable under the condition of μ s
>> μa. Under the diffusion approximation, the effective attenuation coefficient of the medium μ eff
will be given by

eff  3  a  a   s'  ,  s'  (1  g ) s

4.3

Here, μs/ is the reduced scattering coefficient of the medium and g is known as anisotropy
parameter. The scattering phase function of the medium p(s, s/) is the probability function of a
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photon for scattering in s/ direction while before scattering it was travelling in s direction. If the
scattering is axially symmetric relative to the propagation direction before scattering, then for a
random scattering medium the scattering phase function will only depend on the angle between
the direction of propagation before scattering s and scattering direction s/. In this case, the
anisotropy factor will be given by Equation 4.4


g   p( ) cos  2 sin d

4.4

0

Here θ is the angle between s and s/. The value of g will be in the range of -1 to +1. When g > 0,
that means the scattering predominantly takes place in the forward direction whereas g < 0
means dominant backward scattering and g = 0 corresponds to isotropic Rayleigh scattering [4.2
– 4.3].
So, in case of biological tissue, the light fluence of a collimated incident beam will be
determined by the diffused photons or μeff as in Equation 4.3 for the region z >> 1/μt and for the
region corresponding to a smaller depth the light fluence will be determined by the μ t as in
Equation 4.2 [4.4]. The light fluence Φ, which can be expressed by Equation 4.5, is the integral
of light radiance over all the possible directions.

( x)    ( x, s)ds

4.5

Where υ (x, s) is the light radiance. The unit of fluence is watt/cm2.
4.2: Multiwavelength PA Pixel
The tissue and its major constituents (water, oxyhemoglobin and deoxyhemoglobin in blood,
lipid, fat, melanin, collagen, etc) have widely varying absorption spectra [4.5] in the NIR region
that not only provide abundant contrast features, but also open the door for PA imaging based
spectroscopy with multiwavelength PA imaging. In case of multiwavelength PA imaging,
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different PA images of the same tissue sample are taken using different wavelengths of a tunable
laser. The initial acoustic pressure p, generated following the absorption of the optical energy at
time t=0 can be expressed by Equation 4.6 [4.4]

p  h  a E0 where h   a E0 and  

c 2
Cp

4.6

Here, h is the spatial distribution of the absorbed energy density by the object/tissue and Γ is a
tissue property known as the Grueneissen parameter. The parameters β and Cp represent isobaric
volume expansion coefficient and heat capacity per unit mass of the spherical PA absorber, while
c and E0 represent the velocity of PA wave inside the absorber and input laser fluence received
by the absorber. Γ is basically the conversion factor between the absorbed optical energy density
and the generated acoustic pressure. From Equation 4.6, it is clear that the acoustic pressure
depends on the distribution of absorption coefficient throughout the tissue and so the C scan PA
image pixels depend on the absorption coefficient values.
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Figure 4.1: Multiwavelength PA imaging
As shown in Figure 4.1, a tissue sample [represented by the light green cartoon], which contains
different light absorbing tissue constituents or chromophores [represented by different colored
circles inside the tissue] with different optical absorption properties, are irradiated with different
wavelengths and as a results, PA images with different contrasts of the same tissue sample are
acquired. Generally, the wavelengths are chosen in such a manner, that each wavelength
corresponds to the peak of the absorption spectrum of a particular chromophore. The
spectroscopic application of PA imaging aims for quantitative determination of the concentration
of specific chromophores present in the tissue which can be further used for functional imaging
as well as non-invasive tissue characterization [4.6, 4.7].
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4.2.1 Literature Review
Laufer et al. [4.8] determined the blood oxygen saturation in a cuvette from the PA spectra taken
at multiple wavelengths in the range of 740 nm to 1040 nm. Allen et al. [4.9] performed
spectroscopic PA imaging of human arterial tissue ex vivo to demonstrate the feasibility of
detecting the presence of lipid in human aorta. Zhang et al. [4.10] measured dynamic blood
oxygen saturation variation under different physiological states from PA microscopy data
acquired in vivo from Sprague Dawley rats. As malignant tumor growth is generally associated
with the formation of additional vasculature for providing necessary nutrients required for the
growth [4.7], so the malignant tumors are generally richer in blood than benign or normal tissue.
In the NIR region, the absorption coefficient of blood is orders of magnitude higher than that of
the normal tissue [4.11]. So the stronger optical absorption in the NIR wavelength range by the
blood rich malignant tumors will generate PA signals with higher amplitude than the amplitude
of the background PA signal generated by the normal tissue. Generally, the malignant tumors are
expected to be hypoxic (oxygen deficient), i.e. the concentration of deoxyhemoglobin is
expected to be higher in the malignant regions than benign or normal tissue [4.7]. So if two PA
images of a tissue specimen containing cancer are acquired at two specific wavelengths
corresponding to the absorption spectra peaks of deoxyhemoglobin and oxy hemoglobin, then
there will be significant difference in contrast between these two images for the cancer region.
Using two wavelength PA imaging, while the wavelengths were tuned to absorption spectra
peaks of deoxyhemoglobin and oxyhemoglobin, Oraevsky et al. acquired in vivo PA images of
patients with breast cancer [4.11].
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4.2.2 Prostate Specimen Results
Using marked histology slides as ground truth, the ROIs corresponding to malignant, benign and
normal tissue were identified in the 2D C-scan PA images. Pixels corresponding to the ROIs
from C-scan PA images taken at five different wavelengths were extracted and analyzed.

Figure 4.2: C-scan PA images of a freshly excised human prostate tissue sample taken at five
different wavelengths; (A) Prostate tissue sample (B) Histology slide of the prostate tissue
sample (C) PA image at 760 nm (D) PA image at 800 nm (E) PA image at 850 nm (F) PA image
at 930 nm (G) PA image at 970 nm. ROIs corresponding to the cancer tissue have been marked
by the blue circles whereas the adjacent normal ROIs have been marked by the white circles in
B, C, D, E, F and G.
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Figure 4.2A shows the photograph of a typical prostate specimen before the PA imaging was
done. Figure 4.2B shows the scanned histology slide of the prostate specimen shown in Figure
4.2A. Five C-scan PA images, formed using the PA data acquired at five different wavelengths
are shown in Figure 4.2C – 4.2G. In Figure 4.2B – 4.2G, the ROIs corresponding to malignant
prostate are shown using blue circles while the adjacent normal prostate regions are shown by
white circles.
30 Patients were involved in the study for ex vivo PA imaging with excised prostate specimens.
Data from a total of 53 ROIs were analyzed. According to the histopathology analysis performed
by the genitourinary (GU) histopathologist, among the 53 ROIs, 19 ROIs were malignant, 8
ROIs were Benign Prostate Hyperplasia (BPH) and the rest were normal.
Two sample two tailed t-test was performed with the pixel values extracted from the ROIs in the
2D C-scan images to find out whether there was statistically significant difference between the
PA pixels corresponding to ROIs of different tissue types. Figure 4.3 shows the results of the ttest performed at 5 % significant level with the values of the PA pixels corresponding to
malignant vs. normal, malignant vs. BPH, BPH vs. normal and malignant vs. nonmalignant. The
ROIs corresponding to BPH and normal prostate tissue are grouped into the ‗nonmalignant‘
category.
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Figure 4.3: Comparison of PA pixel values between different prostate tissue types (A) malignant
vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs. nonmalignant using
two sample two tailed t-test. The dashed lines show the levels corresponding to decision criterion
(p = 0.05).
From Figure 4.3, it can be seen that between malignant and normal prostate tissue, the PA pixel
values are significantly different (p<0.05) at all the wavelengths except at 930 nm. Between
malignant and BPH prostate, besides 800 nm wavelength, PA pixel values are significantly
different (p<0.05) at the other wavelengths. For BPH vs. normal prostate, PA pixel values at all
of five wavelengths are significantly different (p<0.05) while between malignant and
nonmalignant prostate, PA pixel value only at 930 nm is not significantly different (p>0.05).
Two way analysis of variance (ANOVA) test was performed with the PA pixel values
considering tissue category and wavelength as two predictors. Tissue category contains three
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separate groups of tissue namely cancer, benign and normal, while wavelength contains five
different wavelengths used for PA imaging.
Table 4.1: Two way anova test results for PA pixel values between different tissue types and
wavelengths.
Source

Sum Square Degrees
of

Mean

F

p value

83.76

2.30367e-36

Square

Freedom
Tissue category

3.70815e+07 2

18540761

Wavelength

1.05258e+08 4

26314419.7 118.87

5.51165e-96

Tissue

5.02459e+07 8

6280742.6

2.40211e-43

Error

8.89886e+08 4020

221364.7

Total

1.10467e+09 4034

28.37

category*wavelength

Results of the two way ANOVA test shows that means of PA pixel values are significantly
different between different tissue groups as the corresponding p value is very small [2e-36] and
PA pixel value means are also different between different wavelength groups [p value = 5e-96].
As the p value corresponding to interaction term is very small [2e-43], the effects of wavelength
and tissue category depend on each other.
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4.2.3 Thyroid Specimen Results:
Data from a total of 41 ROIs [collected from 20 patients] were analyzed. According to the
histopathology analysis performed by the histopathologist, among the 41 ROIs, 9 ROIs were
malignant, 18 ROIs were benign and the rest of the ROIs were normal.
Figure 4.4 shows PA images of a particular thyroid sample taken at five different wavelengths.
The thyroid specimen is shown in Figure 4.4A while the corresponding histopathology slide is
shown in the Figure 4.4B. The marked areas in 4.4B are the nodules marked by the
histopathologist. Figure 4.4C shows the histopathology slide overlaid on the thyroid specimen to
identify the nodules in the thyroid specimen. Figure 4.4C has been co-registered with the C-scan
PA images, shown in Figure 4.4D – 4.4H to identify the ROI. The ROIs corresponding to the
malignant region have been marked by the blue circles in Figure 4.4A, and Figures 4.4D – 4.4H.
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Figure 4.4: Photoacoustic images of a freshly excised thyroid tissue sample taken at five
different wavelengths; (A) Excised thyroid tissue sample (B) Digital image of the
Histopathology slide of the thyroid tissue sample (C) Histopathology slide overlaid on the
thyroid tissue sample (D) PA image acquired at 760 nm (E) PA image acquired at 800 nm (F) PA
image acquired at 850 nm (G) PA image acquired at 930 nm (H) PA image acquired at 970 nm.
ROIs corresponding to the malignant tissue have been marked by the blue circles in A, D, E, F,
G, H.
Two sample two tailed t-test was performed with the pixel values extracted from the ROIs in the
2D C-scan images to find out whether there was statistically significant difference between the
PA pixels corresponding to ROIs of different types. Figure 4.9 shows the results of the t-test
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performed at 5 % significant level with the values of the PA pixels corresponding to malignant
vs. normal, malignant vs. benign, benign vs. normal and malignant vs. nonmalignant thyroid
tissue. The ROIs corresponding to benign and normal prostate tissue are grouped into the
‗nonmalignant‘ category.

Figure 4.5: Comparison of PA pixel values between different thyroid tissue types (A) malignant
vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs. nonmalignant using
two sample two tailed t-test. The dashed lines show the levels corresponding to decision criterion
(p = 0.05).
From Figure 4.5, it can be seen that between malignant and normal thyroid tissue, the PA pixel
values are significantly different (p<0.05) at all the wavelengths. Between malignant and benign
thyroid also, PA pixel values are significantly different (p<0.05) at the wavelengths. For benign
vs. normal thyroid, PA pixel values at all of five wavelengths are significantly different (p<0.05)
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except for 970 nm while between malignant and nonmalignant prostate, PA pixel values at all the
five wavelengths are significantly different (p<0.05) .
4.3 Chromophore Concentration
As mentioned earlier, the contrast in the PA images is determined by the optical absorption
coefficient of the tissue. The optical absorption at a particular location of the tissue is the sum
total of the optical absorption by the light absorbing tissue constituents or chromophores present
at that particular tissue location. Although there may be various kinds of chromophores present
in a particular tissue sample, for some wavelength ranges, only a few chromophores dominate
the optical absorption. For example, in the NIR wavelength region, primarily deoxyhemoglobin
and oxyhemoglobin dominate the optical absorption while lipid and water provide minor
contributions towards the higher end of the NIR region. Spatially varying absorption coefficient
of a tissue sample at different wavelengths can be recovered from the multiwavelength PA
images of the tissue sample. The relation between the absorption coefficient μa(x, y) at a
particular wavelength and the concentration of different chromophores can be written in the form
of Equation 4.7
N

 a ( , x, y)   ck ( x, y) k ( )

4.7

k 1

Here ck(x, y) is the concentration of the kth chromophore, αk is the specific absorption coefficient
of the kth chromophore at the particular wavelength λ and N is the number of different types of
chromophore present in the tissue sample [4.12]. Inverting Equation 4.7, concentrations of
different chromophores (endogenous chromophores like oxy hemoglobin, deoxyhemoglobin and
for some cases exogenous contrast agents) can be found out from the recovered absorption
coefficients at different wavelengths.
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4.3.1 Literature Review
Chromophore concentration from 1D PA imaging: The simplest form of the PA imaging is 1D
PA imaging. This can be used to find out the variation of optical absorption coefficient along the
depth and from the optical absorption coefficient, concentration of different chromophores can
be recovered. The simplest case where 1D PA imaging can be applicable is the illumination of
homogeneous, non-scattering optically absorbing material by an infinitely wide light beam of
very short duration. The variation of the PA signal along the depth will follow the intensity
variation of the incident light along the depth, given by Lambert Beer‘s law. The optical
absorption coefficient can be calculated by finding out the slope of the exponentially decaying
time dependent pressure data [4.13]. Guo et al., devised a frequency domain method for
determining the optical absorption coefficient values along the depth. They acquired the PA
signals at two different wavelengths, took Fourier transform of each of the PA signals and then
fitted a curve governing by an Equation determined theoretically to the ratio of the magnitudes of
the Fourier transforms of the PA signals. The advantage of working with the ratio of the Fourier
transforms is that the Fourier transfer of the impulse response of the system, which remains the
same irrespective of the wavelength change, cancels out in the ratio. They used this method in an
OR-PAM set up to estimate absolute values of the absorption coefficients in a superficial vein
and artery pair of a nude mouse ear obtained at 561 and 570 nm [4.14]. In case of multilayer
media with different optical absorption coefficients corresponding to different layers,
exponentials with different decay constants can be fitted to the parts of the curves corresponding
to the separate layers. Karabutov et al. derived an expression to recover the absorption
coefficient as a function of depth from the acquired PA data when the absorption coefficient of
the medium varies continuously with depth. Using that expression, they recovered the depth
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dependent absorption profiles for solutions of magnetite particles in oil [4.15]. Paultau et al.
slightly modified this expression to account the diffraction effects and used it to find out the
absorption profiles from the time dependent pressure signal for dyed gelatin phantoms [4.16].
For all the above three cases, it has been assumed that the medium is nonscattering. If scattering
is considered, then the exponential decay of the fluence from the surface of a tissue will be
governed by μt or μeff, not μa as mentioned in section 4.1. Due to backscattering, the maximum
light fluence may occur not on the surface, but at a certain depth inside the tissue. Oraevsky et al.
considered the effect of scattering and with the help of measured diffused reflected light from the
surface, fitted an decaying exponential to the time dependent PA data to find the corresponding
μeff. Then from the amplitude of the pressure data and recovered μ eff, they found the
corresponding values of μa, μs and g [4.17, 4.18]. For 1D methods to be applicable, the acoustic
wave generated by the sample must be planar and perpendicular to z direction, the fluence
distribution must remain constant in the X-Y plane and the optical properties of the material
must also remain invariant in the X-Y plane [4.4]. Though for most of the practical situations,
these conditions will not be satisfied, but the lack of complexity as well as the ease of
computation involved with these methods makes them good approximations of the higher
dimensional methods [4.4]. Laufer et al. used a 1D method to compute the blood oxygenation
saturation fairly accurately [4.19].
Chromophore concentration from single point measurements: As mentioned earlier, there may be
certain limitations associated with the 1D methods for optical property recovery from acquired
PA signals. In actual tissue samples, the optical properties of the materials and the light fluence
distribution in the X-Y plane will not be invariant. To overcome these difficulties partially, some
methods estimate the optical parameters of the materials from the measured PA pressures at
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separate single points. For these methods, the information is extracted separately for each point
i.e. from each A-line PA signal corresponding to a particular tissue location. In a phantom study,
Sivaramakrishnan et al. measured the blood oxygenation saturation from the PA signals at
multiple wavelengths of a uniform cylindrical absorber of known size in a purely scattering
medium. They proposed that under certain experimental conditions, the amplitude of the PA
signal varies linearly with the optical absorption coefficient of the absorber [4.22 – 4.23]. Wang
et al. measured total concentration of hemoglobin and hemoglobin oxygen saturation in rat brain
vasculature from in vivo PAT images. They measured the transmitted light intensity through the
skin and the brain of the rats ex vivo at two different wavelengths, used these measurements to
calibrate the PA signals at the same two wavelengths and then used the calibrated PA signals to
obtain the concentration measurements considering the PA signal varies linearly with absorption
coefficient [4.24]. To measure the wavelength dependence of the light fluence inside the tissue
under the same experimental conditions, Maslov et al. introduced a plain black absorbing film
with a spectrally flat absorption coefficient inside the tissue at the same depth as that of the blood
vessel, measured the PA signal due the black film to calibrate the PA signals from the blood
vessels at different wavelengths and then used those calibrated PA signals to compute the blood
oxygenation saturation [4.25 – 4.27]. Rajian et al. proposed to replace the film of black ink by an
exogenous contrast agent for measuring the dependence of light fluence inside the tissue at
different wavelengths [4.28]. Laufer et al. proposed a model based inversion technique to recover
both optical absorption and scattering parameters of the material using prior knowledge of the
shape and size of the tissue constituents. They built a phantom to mimic the real tissue and
recovered the absorption and scattering coefficients from the point measurements using light
transport as well as acoustic propagation models [4.29]. They made their method more
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generalized by using 3D acoustic propagation model and 2D PA images rather than a number of
A-line PA signals to recover the quantitative estimates of hemoglobin and oxyhemoglobin
concentration [4.30].
4.3.2 Procedure
To recover the chromophore concentration, we adopted a method which suited with our
experimental configuration and dimension of the tissue samples. The method was a fusion of the
two approaches mentioned above.

Since all the tissue samples we imaged did not have

significance thickness [most of the samples have thickness within 3 mm], we considered that the
light fluence distribution inside the tissue in the X-Y plane is invariant as in 1D PA imaging
approach. On the other hand, we assumed that the optical properties of the tissue sample will be
different at different points as in single point measurements approach. Based on these two
assumptions, we proposed that the amplitudes of the acquired localized PA signals at different
points at a specific wavelength were proportional to the values of optical absorption coefficient
at those particular points at that specific wavelength. Thus we modified Equation 4.7 to form
Equation 4.8 by replacing μa(λ, x, y) with the acquired PA signal amplitude Pλ(x ,y) for each
point of measurement.
N

KP  ( x, y)   ck ( x, y) k

4.8

k 1

Here K is the proportionality constant which is related to ultrasound parameters and local optical
fluence inside the tissue. Thus solving Equation 4.8, we recovered the concentrations of four
different types of chromophores from five different C-mode images taken at five different
wavelengths for one tissue sample. As mentioned earlier, since in the NIR wavelength region,
the specific absorption coefficients, αk(λ) of deoxyhemoglobin, oxyhemoglobin, lipid and water
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are greater than that of other types of chromophores, so the concentrations of these four
chromophores were recovered from the C-mode PA images. The five wavelengths at which the
PA images of each sample were acquired are 760nm, 800nm, 850nm, 930nm and 970nm.

Figure 4.6: Absorption spectra of chromophores (A) Absorption spectra of deoxyhemoglobin,
oxyhemoglobin, (B) Absorption spectra of fat/lipid and water. Laser wavelengths, employed for
acquiring PA images are shown by the dashed blue lines. [4.31]
As it can be seen in Figure 4.6, the wavelengths have been selected in such a way that each
wavelength matches with the corresponding wavelength at which one of the four chromophores
has its peak specific absorption coefficient. The matched pairs of chromophore with its peak
absorption coefficient wavelength are deoxyhemoglobin-760 nm, oxyhemoglobin-850 nm, fat930nm and water-970nm. The wavelength 800 nm has been selected as at this wavelength, the
specific absorption coefficients of both deoxyhemoglobin and oxyhemoglobin are equal.
Now, Equation 4.8 can be solved for different values of ck using Equation 4.9.
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Now, as we can see from Figure 4.6, the values of specific absorption coefficients of
deoxyhemoglobin and oxy hemoglobin are nearly two order of magnitude higher than that of
lipid and water, so we recovered concentrations of deoxyhemoglobin and oxyhemoglobin only
from the images taken at five wavelengths using a modified version of Equation 4.9.
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Similarly, we recovered the concentration of fat and water only from the five different C-mode
images, since the specific absorption coefficient of fat and water are within the same range in the
NIR region. For that, the modified version of Equation 4.9 is the following
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4.3.3 Prostate Specimen Results

Figure 4.7: Parametric images representing spatially varying chromophore concentration of a
freshly excised human prostate tissue sample (A) Prostate tissue sample (B) Histology slide of
the prostate tissue sample (C) Parametric image showing deoxyhemoglobin concentration (D)
Parametric image showing oxyhemoglobin concentration (E) Parametric image showing lipid
concentration (F) Parametric image showing water concentration. ROIs corresponding to the
cancer tissue have been marked by the blue circles whereas the adjacent normal ROIs have been
marked by the white circles in B, C, D, E and F.
Figure 4.7A shows the photograph of a typical prostate specimen before the PA imaging was
done. Figure 4.7B shows the digital histology slide of the prostate specimen in Figure 4.7A.
Using recovered spatially varying chromophore centration according to Equation 4.9, parametric
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images were created. The parametric images represent the varying chromophore concentration in
the cross sectional plane as each pixel represents concentration of a certain chromophore at the
corresponding spatial location in the tissue specimen. Four parametric images representing
spatially varying concentration of deoxyhemoglobin, oxyhemoglobin, lipid and water are shown
in Figure 4.7C – 4.7F. In Figure 4.7B – 4.7F, the ROIs corresponding to malignant prostate are
shown using blue circles while the adjacent normal prostate regions are shown by white circles.
Data from a total of 53 ROIs [collected from 30 patients] were analyzed. According to the
histopathology analysis performed by the GU histopathologist, among the 53 ROIs, 19 ROIs
were malignant, 8 ROIs were BPH and the rest of the ROIs were normal.
Two sample two tailed t-test was performed with the chromophore concentration values
extracted from the ROIs in the parametric images to find out whether there was statistically
significant difference between chromophore concentrations corresponding to ROIs of different
types. Figure 4.6 shows the results of the t-test performed at 5 % significant level with the
chromophore concentration values corresponding to malignant vs. normal, malignant vs. BPH,
BPH vs. normal and malignant vs. nonmalignant. The ROIs corresponding to BPH and normal
prostate tissue are grouped into the ‗nonmalignant‘ category.
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Figure 4.8: Comparison of chromophore concentration between different prostate tissue types
(A) malignant vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs.
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding
to decision criterion (p = 0.05).
From Figure 4.8, it can be seen that between malignant and normal prostate tissue, the
chromophore concentration values are significantly different (p<0.05) for all of the four
chromophores except water. Between malignant and BPH prostate, besides oxyhemoglobin and
lipid, chromophore concentration values are significantly different (p<0.05) for other
chromophores. For BPH vs. normal prostate and malignant vs nonmalignant, only water
concentration is not significantly different (p>0.05).
Two way ANOVA test was performed with the chromophore concentration values considering
tissue category and chromophore type as two predictors. Tissue category contains three separate

62

groups of tissue namely cancer, benign and normal, while chromophore type consists of
deoxyhemoglobin, oxyhemoglobin, lipid and water.
Table 4.2: Two way ANOVA test results for chromophore concentration values between
different tissue types and chromophores.
Source

Sum

Degrees of Mean

F

p value

Square

Freedom

Square

Tissue category

18.15

2

9.074

23.07

1.12233e-10

Chromophore

305.36

3

101.787

258.85

1.80038e-150

Tissue

65.87

6

10.979

27.92

1.12749e-32

Error

1264.63

3216

0.393

Total

1701.19

3227

category*chromophore

Results of the two way ANOVA test shows that means of chromophore concentration values are
significantly different between different tissue types as the corresponding p value is very small
[1e-36] and chromophore concentration means are also significantly different between different
chromophore types [p value = 2e-150]. As the p value corresponding to interaction term is very
small [1e-32], the effects of chromophore types and tissue types depend on each other.
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4.3.3 Thyroid Specimen Results
Figure 4.9A shows the photograph of a typical thyroid specimen before the PA imaging was
done. Figure 4.9B shows the scanned histology slide overlaid on the image of the thyroid
specimen. Using recovered spatially varying chromophore centration, parametric images were
created. The parametric images represent the varying chromophore concentration with a cross
sectional view as each pixel represents concentration of a certain chromophore at the
corresponding spatial location in the tissue specimen. Four parametric images representing
spatially varying concentration of deoxyhemoglobin, oxyhemoglobin, lipid and water are shown
in Figure 4.9C – 4.9F. In Figure 4.9B, malignant region was marked with blue ink by the
pathologist. In Figures 4.9C – 4.9F, the ROIs corresponding to malignant thyroid are shown
using blue circles.
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Figure 4.9: Parametric images representing spatially varying chromophore concentration of a
freshly excised human thyroid tissue sample; (A) Thyroid tissue sample (B) Histology slide of
the thyroid tissue sample overlaid on the thyroid specimen image (C) Parametric image showing
deoxyhemoglobin concentration (D) Parametric image showing oxyhemoglobin concentration
(E) Parametric image showing lipid concentration (F) Parametric image showing water
concentration. ROIs corresponding to the cancer tissue have been marked by the blue circles in
B, C, D, E and F.
Two sample two tailed t-test was performed with the chromophore concentration values
extracted from the ROIs in the chromophore concentration parametric images to find out whether
there was statistically significant difference between chromophore concentrations corresponding
to ROIs of different types. Figure 4.10 shows the results of the t-test performed at 5 % significant
level with the values of the parameter corresponding to malignant vs. normal, malignant vs.
benign, benign vs. normal and malignant vs. nonmalignant thyroid tissue. The ROIs
corresponding to benign and normal thyroid tissue are grouped into the ‗nonmalignant‘ category.
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Figure 4.10: Comparison of chromophore concentration between different thyroid tissue types
(A) malignant vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs.
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding
to decision criterion (p = 0.05).
From Figure 4.10, it can be seen that between malignant and normal thyroid tissue, the
chromophore concentration values are significantly different (p<0.05) for all of the four
chromophores. Between malignant and benign thyroid, besides oxyhemoglobin and lipid,
chromophore concentration values are significantly different (p<0.05) for other two
chromophores. For benign vs. normal and malignant vs. nonmalignant thyroid tissue, all of the
four chromophore concentrations were significantly different (p<0.05).
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CHAPTER 5: Feature Extraction from Frequency Domain PA Signal
5.1 Modeling of 1D PA Signals
A detail study of the temporal characteristics of the photoacoustic waves, generated by different
absorbers following absorption of short pulse laser light is extremely important for PA image
analysis. In this study, features were extracted from 2D C-scan PA image pixels as well as time
dependent PA A-line signals corresponding to different tissue pathologies. As it has been proved
that, temporal features and corresponding frequency contents of the PA signals depend on the
geometries of the particular PA absorbers [5.1], modeling of PA signals generated by different
types of PA absorbers can help to obtain a preliminary idea about the relationships between the
temporal and spectral features of PA signals with the corresponding absorber geometries.
Studying the modeled PA signals and corresponding frequency contents, the impact of the
limited bandwidth of the detection system [transducers] on the detected PA signals can also be
understood. Detail discussions about the physics of PA effect and PA wave generation are
available in literature [5.1 – 5.5].
Here time dependent PA signals generated by absorbers of various different geometries have
been modeled. The PA signals have been modeled using the expressions generated by Diebold et
al. [5.1 – 5.3]. The frequency contents of the PA signals have been also computed.
The increment of pressure in a tissue like medium due to the localized heating produced by the
absorption of light energy, is given by Equation 5.1.
 V 
p   B
  BT
 V 

5.1

Here p is the increment of pressure from the equilibrium value, B is the isothermal bulk modulus,
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β is the isobaric volume expansion coefficient, ΔT is the temperature increment, V is the original
volume and ΔV is the volume increment [5.4].
Now from the above equation it is apparent that the value of p will be maximum when there will
be no volume increment i.e. ΔV will be zero. This is known as stress or inertial confinement. The
stress confinement can be achieved if the pulse duration of the incoming laser light is much
smaller than the characteristics time for acoustic relaxation, tac , given by Equation 5.2.

t ac 

1

ac

5.2

Here c is the speed of the acoustic wave inside the tissue and µa is the absorption coefficient of
the tissue [5.4]. If the stress confinement condition is satisfied then the shape of the excited
acoustic wave follows the spatial distribution of the heat source [5.2].
The thermal relaxation time tth is given by Equation 5.3.

tth 

1

 a2 

5.3

Here χ is the thermal diffusivity of the medium.
Generally the value of tth is larger than tac i.e. the thermal relaxation takes place much slowly
than the acoustic relaxation. So, if the incoming laser pulse satisfies the stress confinement
condition, then it is bound to satisfy the thermal confinement condition. The thermal
confinement condition ensures that heat generated by the absorption of laser light will be
confined in the irradiated volume during the laser pulse and cannot escape via heat conduction
[5.4].
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The temporal evolution of the thermoelastic stress i.e. the stress generated due to heat produced
by the absorption of the laser light, contains two distinct stages. In the first stage, the maximum
stress p=BβΔT, has been generated under stress confinement condition. In the second stage, the
forces caused by the thermal stress lead to the displacements which propagate as the broadband
longitudinal acoustic waves through the medium [5.4].
The coupling equations, describing the temperature and pressure perturbations due to the
photoacoustic wave, can be derived from the linearized mass, momentum and energy
conservation equations. As described earlier, under the condition tth >> tac, the two coupling
equations can be merged together to form the following photoacoustic wave equation [5.2].

2 p 

1 2 p
 H

2
2
c t
C p t

5.4

Here, H is the heat deposited in the medium per unit volume per unit time and Cp is the heat
capacity per unit mass.
For 1D PA wave, the Laplacian operator in Equation 5.4 reduces to the second derivative with
respect to z, the direction of propagation of the photoacoustic waves. Using a suitable Green‘s
function, the solution for the 1D version of Equation 5.4 can be expressed as Equation 5.5.

p( z , t ) 

c
2C p



 dz' H  z' , t 

z  z' 

c 

5.5

Here the source of the PA wave is at the origin and the field point (0, 0, z) is any point located on
the positive Z axis away from the source.
Now, if we consider that the PA wave is generated due to the absorption of pulsed laser light of
nanosecond duration, then the heat deposited in the medium, H can be written as Equation 5.6.
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H ( z, t )  a E0 hˆzˆ  t 

5.6

Here E0 is the energy per unit area in the laser beam or energy fluence and hˆzˆ  is the
dimensionless function which describes the spatial deposition of energy arising from the
absorption of the input laser light.
Equation 5.5 can be solved using Equation 5.6 and the solution can be expressed as Equation 5.7

p(ˆ0 ) 

 c   
 E c 2

 ˆ
h(ˆ0 ) ,   a 0 , ˆ0    t    ˆ  ˆ, ˆ 
Cp
0
2
  0  c 

5.7

Here ξ is a generalized coordinate (ξ = z in one dimension and ξ = r in three dimension) and ξ 0 is
a constant. Equation 5.7 shows that under the condition of stress confinement which is satisfied
here since input laser pulses are of nanosecond duration, the spatial deposition of heat in the
medium from a short pulse laser source is followed by the time profile of the photoacoustic
wave. The factor 2 in the numerator has been introduced to take care of the fact that the initial
pressure will be equally distributed to the two waves propagating along the positive Z axis and
negative Z axis.
The thermo-acoustic pressure wave generation efficiency can be expressed by a dimensionless
parameter Γ, which is defined by Equation 5.8.



c 2
Cp

5.8

Using equation 5.7, expressions for initial PA pressure generated by absorbers of different
geometries following uniform illumination of short duration [nanosecond] pulsed laser light, can
be formulated.
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5.1.1 Thin Layer
The pressure generated at the field point z on the Z axis due to uniform absorption of pulse laser
light by a vanishingly thin layer of high absorbing material is given by Equation 5.9.

p(ˆ) 


 (ˆ)
2 a z0

5.9

 c  z  z0 
Where ˆ    t 
c 
 z0 
Here z0 is the distance of the thin layer from the origin. The thin layer is perpendicular to the Z
axis.
Similarly, the pressure generated at the field point (0, 0, z) due to the absorption of infinitely
wide beam of light by a thin layer of absorbing material of thickness z 0, placed perpendicular to
the z axis and having infinite dimensions along X & Y axes, is given by Equation 5.10.
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The starting edge of the thin layer coincides with the origin. Here only the wave propagating
along positive Z axis has been considered because, the portion of wave propagating along
negative Z axis will not reach the filed point. . The starting edge of the thin layer coincides with
the origin. The exponential term has been introduced in the expression to take care of the decay
in the intensity of the incoming laser light according to Lambert-Beer law [5.7].
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Figure 5.1: PA signal for a vanishingly thin high absorbing layer placed at a distance 0.5 cm
from the origin (a) Initial PA signal (B) Amplitude spectrum of the initial PA signal.
Figure 5.1 shows the PA signal generated by a vanishingly thin absorbing layer, placed at z 0 =
0.05 cm. The field point was at z = 0.5 cm. The amplitude spectrum of the PA signal generated
was shown in Figure 5.1 B. As the PA signal is a delta function, the corresponding amplitude
spectrum was uniform for all the frequencies.
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Figure 5.2: PA signal generated by a thin film of thickness 0.05 cm (a) Initial PA signal (B)
Amplitude spectrum of the initial PA signal.
Figure 5.2 shows the PA signal generated by a thin film of thickness 0.05 cm. The field point
was at z = 0.5 cm. Figure 4.5B shows the corresponding amplitude spectrum.
For generating both Figure 5.1 and 5.2, following material properties were assumed.
μa = 0.6 cm-1 and Γ = 0.8.
The incident laser fluence E0 was assumed to be unity.
5.1.2 The Sphere
Equivalent form of equation 5.5 can be found and solved in three dimensions to find the
properties of the photoacoustic wave generated due to absorption of pulsed laser light by a
uniform spherical source. Using a similar approach, the expression of the pressure generated due
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to absorption of light by a spherical shell can also be found. When the source is a spherical shell,
then the expression of the pressure generated is given by Equation 5.11.

p(ˆ) 

c
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Here, r0 is the radius of the spherical shell and r is the field point or the point of observation.
The expression of pressure for a uniformly irradiated sphere is given by
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Using Equations 5.11 and 5.12, the PA waves generated by uniformly illuminated spherical shell
and spherical droplet were simulated and the results are shown in Figure 5.3 and 5.4. The radii of
the spherical shell and the sphere were 0.05 cm. Field points for both the cases were at 0.5 cm.
The material properties considered for the two cases were following
μa = 0.6 cm-1 and Γ = 0.8.
The incident laser fluence was assumed to be unity.
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Figure 5.3: PA signal generated by a uniformly irradiated spherical shell of radius 0.05 cm (a)
Initial PA signal (B) Amplitude spectrum of the initial PA signal.

Figure 5.4: PA signal generated by a uniformly irradiated sphere of radius 0.05 cm (a) Initial PA
signal (B) Amplitude spectrum of the initial PA signal.
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5.1.3: The Cylinder
The expression for PA wave generated by a cylindrical absorber, uniformly irradiated by pulsed
laser light is given by Equation 5.13.
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ρ0 is the radius of the cylinder. Equation 5.13 was evaluated by performing numerical integration
using Bode‘s rule [5.6] to model the PA wave generated by a cylinder with radius 0.05 cm. The
field point or the point of observation was ρ = 0.5 cm. Figure 5.5A shows the PA signal
generated by the cylinder while Figure 5.5B shows the corresponding PA amplitude spectrum.
The material properties of the cylinder was following
μa = 0.6 cm-1 and Γ = 0.8.
The incident laser fluence was assumed to be unity.
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Figure 5.5: PA signal generated by a uniformly irradiated cylinder of radius 0.05 cm (a) Initial
PA signal (B) Amplitude spectrum of the initial PA signal.
The amplitude spectrum was modeled according to the analytical expression given in Equation
5.14 [5.3].
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and tˆ 
where ω is the angular frequency. d̂ and ĉ represent the ratio of
0

densities and velocities of sound inside and outside of the cylinder. J and H represent Bessel
function and Hankel function. The subscript for J represents the order of the Bessel function
whereas the subscript and superscript within parenthesis for H represent the order and kind of the
Hankel function respectively.

Here d̂ and ĉ were considered unity and c = 0.1562 cm/µs.
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Using these models, a clear idea can be obtained about how the geometry of different absorbers
affect temporal features and corresponding frequency content of the generated PA signals. These
models were the foundation of the extensive simulation study performed later [section 5.2.2] to
find out the capability of the frequency analysis technique for our limited bandwidth PA
acquisition system.
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5.2 Frequency Domain Analysis
As the spectrum of Photoacoustic (PA) radio frequency (RF) signals contain significant
information about the structure of PA absorbers, parameters extracted from PA spectrum can be
potentially used to differentiate between different tissue pathologies. Quantitative reconstruction
of chromophore concentration or optical properties of soft tissue from the multispectral PA
image pixels is very difficult as the pixel values depend on several factors like the optical
absorption and scattering inside the tissue, frequency dependent acoustic attenuation etc.
Although there are several methods proposed by different research groups for quantitative
recovery of absorption property and chromophore concentration, some of the methods can be
applied to only specific cases i.e. their application is limited by the assumption on which they
have been built, while the more general methods have been tested only in simulation [5.7]. An
alternative approach for tissue characterization using PA data is the analysis of the PA frequency
spectrum as it carries significant information about the shape and size of the PA absorbers [5.2].
5.2.1 Literature Review
Frequency domain analysis in which spectral parameters namely slope, midband fit and intercept
are extracted from the power spectra of the time dependent signals in the usable bandwidth is a
widely used technique in pulse echo US imaging for tissue characterization [5.8, 5.9].
Application of this technique on the PA image data is more recent. Using frequency domain
analysis on high frequency PA signal generated by ex-vivo ocular tissue, Silverman et. Al. [5.10]
found that spectral slope and midband fit parameters were higher around iris pigment epithelium.
Kuman et al. [5.11] implemented frequency domain analysis technique in an in vivo PA imaging
study with prostate cancer murine model involving 7 rats and they showed that midband fit and
intercept parameters were significantly different between malignant and normal tissue regions. In
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a phantom study, slope values corresponding to two different diameter microsphere distribution,
were shown to be significantly different from each other by Yang et al. [5.12]. Using a
simulation study, a series of hypothesis relating the size and distribution of the spherical PA
absorbers with extracted PA spectral parameters was derived by Xu et al. [5.13] and they
validated those hypotheses using a phantom study. Hysi et. al. [5.14] studied the change in PA
spectral parameters with the change of Red Blood cell (RBC) aggregation and oxygenation using
experimentally acquired PA signal generated by Porcine RBCs along with a Monte Carlo based
theoretical model. In a phantom study with microspheres, Chitnis et al. [5.15] investigated the
effect of effective absorber size extracted from the high frequency PA spectrum, slope and
midband fit on the mean absorber diameter of the microspheres. Xu et al. [5.16] performed exvivo as well as in situ experiments on mouse models to investigate the feasibility of
differentiating fatty liver from normal liver using PA spectral parameters. Although the
frequency domain analysis is not entirely independent of light absorption and scattering inside
the overlying tissue, we postulate that it may provide additional information about the dimension
of PA absorbers and that information may be used to differentiate different tissue pathologies.
This study presents the results of moderately large scale studies of frequency analysis of PA
signal data collected from freshly excised human prostate and thyroid tissue samples. What is
unique about this work is that the experimental study was preceded by a detailed simulation
study in which the system specific [for the limited bandwidth system which was used to acquire
experimental data] capabilities and limitations of PA frequency analysis were determined.
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5.2.2 Simulation Study
The overall goal of the simulation study was to assess the utility of the power spectrum analysis
of PA signal captured by our low frequency limited bandwidth system and thereby validate the
use of power spectrum analysis on the PA data accumulated on ex vivo specimens. The
simulation study was divided into three parts. In PA absorber radius range, the range of the
radius of the spherical PA absorbers for which the power spectrum analysis is appropriate to
perform, was determined. This range of radius or limitation on the value of the radius of the PA
absorber is due to the finite usable bandwidth [2.4 MHz – 7.4 MHz] of our PA imaging system.
The usable bandwidth is the frequency range within -10 dB of the peak of one way transducer
power spectrum. In Spectral parameter relationship with absorber radius, we investigated the
relationship of the spectral parameters with mean radius within the predetermined radius range.
In Resolving power of the power spectrum analysis, we performed statistical analysis to
investigate whether the spectral parameters are significantly different for absorbers with different
radius. We used spherical PA absorber for the simulation study as it is easier to simulate time
domain PA signals generated by spherical absorbers than cylindrical absorbers. The frequency
spectrum of PA signal generated by a spherical absorber is similar to that of a cylindrical
absorber.
PA absorber radius range: To determine the range of radius of the spherical absorbers we
studied amplitude spectrum of the PA signal generated by the spherical absorbers. The time
dependent PA signal generated by a spherical absorber is given by [5.2]

  c 2 E0  ct 
1   for rd  r  t  rd  r
p(t )   a
 2C

c
c
p

 rd 

5.15

Here µa, β, Cp represent optical absorption coefficient, isobaric volume expansion coefficient and
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heat capacity per unit mass of the spherical PA absorber, while c and E0 represent the velocity of
PA wave inside the absorber and input laser fluence received by the absorber. Radius of the
absorber and the distance between the observation point and the center of the absorber are
represented by r and rd. The time dependent PA amplitude is represented by p(t). The amplitude
spectrum of the PA signal can be found out by taking Fourier transform of Equation 5.15.
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Here P(f) represents the amplitude spectrum of the time dependent PA signal The power
spectrum of the PA signal in dB scale is given by Equation 5.17.
pdB  20 log10 P( f )

5.17

Figure 5.6: (A) Normalized Amplitude spectrum of PA signal generated by spherical absorbers
of different radii, (B) corresponding Power spectrum in dB.
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Figure 5.6 shows the normalized power spectrum of the PA signal generated by spherical
absorbers of different radii. It can be seen that with the increase of the radius, width of the
primary lobe decreases and vice versa. As linear regression was to be performed for extracting
spectral parameters so the power spectrum analysis would be appropriate only when
approximately linear region of the power spectrum fell within the usable bandwidth. We
observed the approximate linearity was preserved only up to the third minimum of the power
spectrum. So we hypothesized that linear regression will be appropriate to perform provided that
portions of the power spectrum beyond the third minimum do not fall within the usable
bandwidth. To further support our hypothesis, we calculated R2 value [100 x R2] corresponding
to the linear regression. The R2 value is a general indicator of how much a regression model can
be improved [5.17]. It was observed that the R2 value degraded significantly if portions beyond
the third minimum were considered for linear regression. This criterion set the higher limit on the
radius of the spherical absorber. We found that, for our system, power spectrum analysis might
be appropriate to perform for PA absorbers of radius up to 240 µm. Furthermore, the frequency
corresponding to the peak of the primary lobe shifted to lower values with increasing radius. This
qualitative observation has strong implications for the extracted parameters.
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Figure 5.7: (A) Power spectrum of 240 µm spherical absorber within usable bandwidth, (B)
Power spectrum of 280 µm spherical absorber within usable bandwidth.
Figure 5.7 shows frequency spectrums corresponding to PA absorbers of radii 240 µm and 280
µm. Figure 5.7A shows the power spectrum generated by PA absorber of 240 µm radius with the
straight line which is best fit to the power spectrum in the usable bandwidth. The two vertical
lines designate the usable bandwidth [2.4 MHz – 7.4 MHz]. It can be seen that the third
minimum point coincides with the maximum frequency in the usable bandwidth. Figure 5.7B
depicts the same as Figure 5.7A for a PA absorber having 280 µm radius. The R2 value
corresponding to the linear regression degrades significantly [From 26.7 to 11.7] for power
spectrum of 280 µm PA absorber.
For determining the lower limit on the PA absorber radius, we inspected the best fit straight lines
to the corresponding power spectrums. When the radius of the PA absorber is below a certain
limit, then slope of the best fit straight line changes sign i.e. it becomes positive from negative
value. While working with the PA signals generated by the actual tissue samples, we obtained
negative slope values for all the cases. This prompted us to ignore the positive slope values and
consequently the corresponding PA absorber radii. So, we decided that the lower limit on the
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radius of the PA absorbers should be the value below which the corresponding slope value
becomes positive. We found that for our system, for a PA absorber having radius below 88 µm,
the corresponding slope value became positive. So the lower limit on the radius of PA absorber
for which the power spectrum analysis is appropriate to apply is 88 µm.

Figure 5.8: Power spectrum with the best fit straight line in the usable bandwidth for (A) PA
absorber with 88 µm radius (B) PA absorber with 87 µm radius. Slope value for (A) is -1.08
dB/MHz and for (B) is 0.23 dB/MHz.
Figure 5.8 shows the power spectrum with the best fit straight lines in the usable bandwidth
corresponding to PA absorbers of 88µm and 87 µm radii. The slope is negative valued [-1.08
dB/MHz] for 88 µm absorber while it becomes positive [0.23 dB/MHz] for 87 µm. For radii
greater than 88 µm, the major portion of the usable bandwidth remains on the right of the first
maximum of the corresponding power spectrum which may be the probable reason for the
negative slope of the best fit straight line. For radii below 87 µm the major portion of the usable
bandwidth shifts to the left of the first maximum of the corresponding power spectrum and so the
slope of the best fit straight line becomes positive. In conclusion, for our PA imaging system
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considering the predominant sign of the slope for the tissue specimens, we believe the
appropriate range of radii for applying power spectrum analysis on the PA signals generated by
the spherical PA absorbers is from 88µm to 240 µm.
Spectral parameter relationship with absorber radius: Here we investigated the relationship of the
spectral parameters with the absorber radii in the radius range determined earlier. We
hypothesized that a ROI corresponding to any particular type of tissue pathology contains light
absorbers whose radii follow a certain statistical distribution around a particular mean value. In a
previous simulation study [5.13], relationship among spectral parameters and absorber radius
was established for PA absorbers of same radius, spatially distributed over a certain volume
following a uniform random distribution. For our simulation study, we assumed that the radii of
the absorbers follow Gaussian distribution around a particular mean value with a given standard
deviation. To negate the effect of the spatial position of the absorbers, we considered all the
absorbers had identical positions with respect to the point of observation. Also to make the study
more realistic, we introduced noise to the simulated PA signals.
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Figure 5.9: Flowchart for the simulation study of the power spectrum analysis on PA signal
generated by Spherical absorbers
The steps of the simulation study, as shown in Figure 5.9, are described below.
Radius selection: The radii of the spherical absorbers were sampled randomly from a Gaussian
distribution with a certain mean and standard division. The standard deviations were chosen as
one fourth of the corresponding mean values.
PA signal Simulation: Time dependent 1D PA signal generated by a spherical PA absorber after
irradiated with a short duration (nanosecond) laser pulse was simulated according to Equation
5.15. Figure 5.10A and Figure 5.10B show the simulated PA signal generated by a spherical PA
absorber of 150 µm radius and its amplitude spectrum.
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Figure 5.10: (A) Simulated PA signal due to a spherical absorber of 150 µm radius (B)
Amplitude spectrum of the PA signal shown in Figure 5.10A.
Noise Addition: Once the PA signal was simulated, white noise was added to the signal. For
choosing appropriate signal to noise ratio (SNR), a number of PA signals, generated by the real
tissue samples were inspected and the minimum SNR among them was found out. The SNR of
white noise added to the simulated PA signal was chosen as equal to the minimum SNR [10] of
real tissue PA data. For determining noise type, noise present in PA signals generated by real
tissue was inspected and it was found that they were best resembled by the white noise. Figure
5.11A shows white noise added to the simulated PA signal in Figure 5.10A while Figure 5.11B
shows the amplitude spectrum of the noisy PA signal.
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Figure 5.11: (A) Noisy PA signal simulated by adding white noise to PA signal in Figure 5.11A,
the signal to noise ratio is 10 (B) Amplitude spectrum of the PA signal shown in Figure 5.11A.
Linear Regression: Fast Fourier Transform (FFT) based power spectrum of simulated PA signal
was computed. Linear regression was performed to find the straight line best fit to the portion of
the power spectrum in the usable bandwidth. Figure 5.12A shows the power spectrum of the
noisy PA signal shown in Figure 5.11A. The vertical straight lines indicate the usable bandwidth
of our PA imaging system.
Parameter extraction: Three parameters namely, slope (dB/MHz), midband fit (dB) and intercept
(dB) were extracted from the best fit straight line. Slope and intercept are the slope and intercept
of the straight line while midband fit is the y-coordinate of the point on the straight line
corresponding to the middle frequency [5 MHz] in the usable bandwidth. Figure 5.12B shows the
portion of the power spectrum in the usable bandwidth along with the best fit straight line.

89

Figure 5.12: (A) Power spectrum of the noisy PA signal shown in Figure 5.11A, the vertical
dashed line indicate the usable bandwidth [2.4 MHz – 7.4 MHz] of our PA imaging system (B)
Power spectrum with the best fit straight line in the usable bandwidth. The values of slope,
midband fit and intercept, extracted from the straight line are respectively -2.21 dB/MHz, -14.10
dB and -3.08 dB. R2 value corresponding to the linear regression in Figure 5.12B is 33.91.
The complete process is performed for a significant number of radius values (N = 100) sampled
from a specific normal distribution with given mean radius. Corresponding to each sampled
radius value, a set of values for the three spectral parameters was obtained. Each parameter was
averaged over N values to obtain one final parameter value corresponding to the given mean
radius.
We performed the simulation study with several Gaussian distributions of radius values. Each
mean radius value was within the range of radius appropriate for our PA system. Figure 5.13
shows the results of the simulation study performed with mean radii 100 µm, 130 µm, 160 µm,
190 µm, 210 µm, and 240 µm. For each mean radius, the corresponding standard deviation is one
fourth of the mean radius.
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Figure 5.13: Mean spectral parameters against the mean radius (A) Slope [dB/MHz] against
mean radius [µm] (B) Midband fit [dB] against mean radius [µm] (C) Intercept [dB] against
mean radius [µm]. Standard deviation of each parameter over N = 100 are the corresponding
error bars.
In Figure 5.13 the three spectral parameters, averaged over N = 100, were plotted against the
mean radii of the spherical PA absorbers. According the hypotheses of Xu et al. [5.13], the slope
should decrease while intercept and midband fit parameters should increase with increasing
radius of PA absorber. Figure 5.13A shows that, besides the last two points, average slope
decreases almost consistently with the increasing mean radius. Figure 5.13C shows that intercept
increase almost consistently with the mean radius apart from the last two radius values, while
Figure 5.13B shows that midband fit increase consistently for all mean radii. We assumed that
the departure of mean slope and intercept from the expected trend for the last two points i.e.
when mean radius was equal to 210 µm and 240 µm, was due to the fact that that those mean
radii were close to the higher bound of the range of radius appropriate for our PA imaging
system.
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Figure 5.14: Average amplitude spectrum and best fit straight lines or linear models having
average spectral parameters corresponding to different mean radii.
Figure 5.14 shows the mean amplitude spectra corresponding to different Gaussian distributions
of radius values. The linear models or best fit straight line were plotted using the average spectral
parameters corresponding to each mean radius.
Resolving power of the power spectrum analysis: Here, we examined the potential of the power
spectrum analysis to differentiate between PA absorbers of different radii. Two sample two tailed
t tests were performed with spectral parameters corresponding to Gaussian distributions of radius
values with different mean radii. Within the appropriate radius range [88 µm – 240 µm], equally
spaced mean radius values were chosen and spectral parameters corresponding to radius values
sampled randomly from normal distributions around the mean radii were computed in the
presence of noise. Two sample two tailed t tests were performed to test whether the spectral
parameters corresponding to successively chosen mean radii were significantly different. We
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started with large gap between the successive mean radius values (40 µm) and gradually
decreased the gap to 10 µm. In this way, we tried to find out the smallest difference between the
mean radii of two different types of PA absorbers for which the corresponding spectral
parameters would be significantly different. Or in other words, we tried to measure the resolving
power of the power spectrum analysis to differentiate among different spherical PA absorbers
within the appropriate radius range.

Figure 5.15: Two sample two tailed t test performed with the spectral parameters corresponding
to different mean absorber radii. The red line is the significance level corresponding to p = 0 05.
The successive absorber radii are (A) 40 µm apart (B) 30 µm apart (C) 20 µm apart and (D) 10
µm apart.
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Figure 5.15 shows the results of the two sample two tailed t test. The red line shows the chosen
significance level p = 0.05. So for any p value higher than the significance level, the
corresponding spectral parameter is significantly different between the corresponding radius pair.
When the difference between the successive mean radii was large (40 µm in Figure 5.15A), the
corresponding spectral parameters were significantly different for almost all the cases. When the
difference between the successive radii was reduced to minimum (10 µm in Figure 5.15D),
spectral parameters for most of the cases were not significantly different. When the difference
was 30 µm, the spectral parameters for majority of the mean radius pairs were significantly
different (Figure 5.15C). So, it can be said, for our PA system, the power spectrum analysis can
differentiate between two different PA absorbers when their radii differ by at least 30 µm,
provided the radii are within the appropriate range.
5.2.3 Frequency Domain Analysis of Tissue Generated PA Data
Frequency domain analysis was performed on 3D PA data generated by excised human prostate
and thyroid specimens collected from patients undergoing surgery for suspected prostate or
thyroid cancer. The objective of this study was to verify the feasibility of differentiating among
malignant, benign and normal prostate/thyroid tissue using frequency domain analysis of the 3D
PA data.
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Figure 5.16: Flowchart of experimental study.
Figure 5.16 shows different steps of the experimental study.
The PA data acquisition and ROI selection process have been explained in detail in Chapter 3.
Power spectrum calculation of the windowed PA signals: Once ROI selection was completed;
power spectra of the preprocessed and windowed PA A-line signals within the ROI were
computed. In this step, the PA A-line signals were corrected for the wavelength dependent laser
input intensity variation using the input laser intensity measurements taken prior to each
experiment. Then wavelength dependent attenuation of laser light during its propagation inside
the prostate tissue was corrected for prostate specimens. The laser light gets attenuated while
propagating through the tissue due to the optical absorption and scattering properties of the
tissue. Using Lambert Beer‘s law, 1D light attenuation was computed along the depth (Z axis)
inside the tissue for the five different wavelengths and these computations were used to correct
the PA A-line signals for the light attenuation at different depths inside the tissue.



/
 z   0 exp  eff z  where eff  3 a  a   s



5.18

95

Equation 5.18 represents the Lambert Beer‘s law used to compute the light attenuation inside the
tissue along the depth. Here µeff, µa, and µs/ are the effective attenuation coefficient, absorption
coefficient, and reduced scattering coefficient of the tissue. Φz and Φ0 are respectively the light
fluence at depth z inside the tissue and at the surface of the tissue. The values of the effective
optical attenuation at five different wavelengths were calculated using the corresponding values
of µa, and µs/ as reported for human prostate [5.18]. The different values of µeff used here were
1.91 cm-1 at 760 nm, 1.79 cm-1 800 nm, 2.01 cm-1 850 nm, 2.14 cm-1 930 nm and 2.71 cm-1 at
970 nm. For thyroid specimens, no correction was performed for depth dependent laser light
attenuation inside tissue, as µeff values at multiple wavelengths could not be found. Once these
corrections were done, the PA A-line signals were time-gated to small sections using a series of
sliding Hamming windows. For determining the width of the Hamming window, the results from
the simulation section were used. We hypothesized that the window should be long enough to
accommodate at least one PA absorber. As found out from the simulation study, for our system,
the power spectrum analysis can be applied successfully for spherical PA absorbers having radii
up to 240 µm. The time duration of resulting signal obtained after convolving PA signal
generated by a PA absorber of 240 µm radius and the impulse response of the our transducer
array is approximately equal to 1 µs. So a series of Hamming windows having 1 µs length were
employed here. During windowing, 30% overlap between Hamming windows on successive
segments of every A-line was used as a compromise between reducing truncation artifacts in
FFT and minimizing overlap.

Power spectrum of each time gated A-line PA signal was

computed by taking square of the FFT of the windowed signal.
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Parameter extraction from the calibrated power spectrum: Each computed power spectrum was
divided by the one way power spectrum of the transducer array to remove the artifacts due to the
finite bandwidth of the transducer. The one way power spectrum of the transducer array was
calculated using the two way [pulse echo] transfer function of the transducer array provided by
the manufacturer. The calibrated power spectrum was converted to dB scale. Linear regression
was performed to find the straight line best fit to the calibrated power spectrum in the usable
bandwidth. The three spectral parameters, slope [dB/MHz], midband fit [dB] and intercept [dB]
were extracted from each best fit straight line [5.19, 5.20].

Figure 5.17: Example of power spectrum analysis on single PA A-line signal (A) C-scan image
PA image of a typical excise prostate specimen (B) Normalized PA A-line signal generated by
the tissue corresponding to the blue colored pixel in 5.17A (C) Power spectrum of the windowed
PA A-line signal along with one way power spectrum of the transducer (both normalized before
conversion to dB scale) in the useable bandwidth region, the vertical dashed lines represent the
boundaries of the usable bandwidth [2.4 MHz – 7.4 MHz] (D) Calibrated power spectrum fitted
to the linear model.
Figure 5.17 shows an example of the power spectrum analysis applied on a particular PA A-line
signal. Figure 5.17A shows the C-scan PA image of a typical excised prostate specimen. Each

97

pixel in the C-scan image corresponds to a PA A-line signal. In Figure 5.17B, the PA A-line
signal corresponding to the pixel marked by blue color in Figure 5.17A is shown. Figure 5.17C
shows the power spectrum of the PA A-line signal and the one way power spectrum of the
transducer. Figure 5.17D shows the straight line fitted with the portion of the calibrated power
spectrum in the usable bandwidth. As mentioned in the simulation section, spectral parameters
slope and intercept are the slope and intercept of the straight line while the midband fit is the
height of the straight line at 5 MHz.
Statistical analysis of the extracted parameters: Two sample two tailed t-test were performed
with the extracted spectral parameters to test whether the spectral parameters were significantly
different between malignant and normal ROIs, normal and benign ROIs, malignant and benign
ROIs, malignant and nonmalignant ROIs for each of the five wavelengths. For each type of ROI
[malignant, benign, normal & nonmalignant], average values of the spectral parameters were
computed and plotted against the five wavelengths.
5.2.4 Prostate Specimen Results
For prostate data analysis, 30 Patients were involved in this study. Data from a total of 53 ROI
were analyzed. According to the histopathology analysis performed by the GU histopathologist,
among the 53 ROIs, 19 ROIs were malignant, 8 ROIs were BPH (Benign Prostate Hyperplasia)
and the rest of the ROIs were normal.
The mean values of the three parameters corresponding to three different types of ROIs were
plotted against the wavelengths in Figure 5.18. The mean values were computed over the
respective number of ROIs that were included into the study corresponding to cancer, BPH and
normal prostate tissue. At each point in all the plots, the error bar and the circle represent the
standard deviation and median value of the corresponding parameter over the respective number
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of ROIs. The ROIs corresponding to BPH and normal prostate tissue were grouped into
‗nonmalignant‘ category and the mean values of the three parameters corresponding to
nonmalignant and malignant ROIs were plotted against wavelengths in Figure 5.19.

Figure 5.18: Plot of average values of the three parameters corresponding to different ROIs
against five different wavelengths (A) Mean slope vs. wavelength (B) Mean midband fit vs.
wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the standard
deviation of the corresponding parameter over the respective number of ROIs. Circles represent
median values of the parameters.

Figure 5.19: Plot of average values of the three parameters corresponding to nonmalignant and
malignant regions against five different wavelengths. (A) Mean slope vs. wavelength (B) Mean
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midband fit vs. wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the
standard deviation of the corresponding parameter over the respective number of ROIs. Circles
represent median values of the parameters.
Two sample two tailed t-test was performed with the parameter values to find out whether there
was statistically significant difference between the parameters corresponding to ROIs of different
types. Figure 5.20 shows the results of the t-test performed at 5 % significant level with the
values of slope, midband fit and intercept corresponding to malignant vs. normal, malignant vs.
BPH, BPH vs. normal and malignant vs. nonmalignant.

Figure 5.20: Comparison of spectral parameters between different prostate tissue types (A)
malignant vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs.
nonmalignant using two sample two tailed t-test. The red lines show the levels corresponding to
decision criterion (p = 0.05).
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From Figure 5.20, it can be seen that between malignant and normal prostate tissue, the spectral
parameters are significantly different (p<0.05) except for the slope at 930 nm and 970 nm.
Between malignant and BPH prostate, besides slope at 800 nm and intercept at 760nm and 970
nm, the three spectral parameters are significantly different (p<0.05). For BPH vs. normal
prostate, intercept at 930 nm and slope at 760nm, 850 nm, 930 nm and 970 nm are not
significantly different (p>0.05) while between malignant and nonmalignant prostate, slope at 930
nm is not significantly different (p>0.05).
Two way ANOVA tests were performed with the three spectral parameters considering tissue
category and wavelength as two predictors. Tissue category contains three separate groups of
tissue namely cancer, benign and normal, while wavelength consists of 760 nm, 800 nm, 850 nm,
930 nm and 970 nm.
Table 5.1: Two way ANOVA test results for slope values between different tissue types and
wavelengths.
Source

Sum

Degrees of Mean

F

Prob>F

Square

Freedom

Square

Tissue category

88.8

2

44.3762

17.77

2.06939e-08

Wavelength

93.4

4

23.3564

9.35

1.59927e-07

Tissue category*wavelength

90.6

8

11.3247

4.54

1.65093e-05

Error

10038.1

4020

2.497

Total

10305.3

4034
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Results of the two way ANOVA test shows that means of slope values are significantly different
between different tissue types as the corresponding p value is small [2e-08] and slope means are
also significantly different between different PA wavelengths [p value = 2e-7]. As the p value
corresponding to interaction term is small [2e-5], the effects of wavelengths and tissue types
depend on each other.
Table 5.2: Two way ANOVA test results for midband fit values between different tissue types
and wavelengths.
Source

Sum

Degrees of Mean

F

Prob>F

Square

Freedom

Square

Tissue category

67844.2

2

33922.1

317.05

1.39004e-128

Wavelength

69552.6

4

17388.2

162.52

3.99605e-129

Tissue category*wavelength

14296.6

8

1787.1

16.7

1.35037e-24

Error

430105.9

4020

107

Total

4034
598211.9

Results of the two way ANOVA test shows that means of midband fit values are significantly
different between different tissue types as the corresponding p value is very small [1e-128] and
midband fit means are also significantly different between different PA wavelengths [p value =
4e-129]. As the p value corresponding to interaction term is very small [1e-24], the effects of
wavelengths and tissue types depend on each other.
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Table 5.3: Two way ANOVA test results for intercept values between different tissue types and
wavelengths.
Source

Sum

Degrees of Mean

F

Prob>F

Square

Freedom

Square

Tissue category

45866.6

2

22933.3

128.92

5.42326e-55

Wavelength

78471

4

19617.8

110.28

2.59023e-89

Tissue category*wavelength

10493.5

8

1311.7

7.37

8.75467e-10

Error

715125.5

4020

177.9

Total

598211.9

4034

Results of the two way ANOVA test shows that means of intercept values are significantly
different between different tissue types as the corresponding p value is very small [5e-55] and
intercept means are also significantly different between different PA wavelengths [p value = 3e89]. As the p value corresponding to interaction term is very small [9e-10], the effects of
wavelengths and tissue types depend on each other.
Discussions: Focus of the simulation study was to evaluate the potential of power spectrum
analysis of time dependent PA signal to differentiate between different tissue pathologies for our
limited bandwidth PA acquisition system.
Appropriate range of radius of the spherical PA absorbers: Depending upon the dimension of PA
absorber, the corresponding PA spectrum can vary significantly while the detection bandwidth
i.e. bandwidth of the US transducer remains fixed. Power spectrum analysis involves linear

103

regression with PA spectrum. As the radius of the spherical PA absorber increases, more
adjacent side lobes fall within the transducer bandwidth and that degrades the goodness of fit
associated with linear regression. In this study, based on the goodness of fit of linear regression,
an upper limit on radius [240 µm] of PA absorber for which the power spectrum analysis would
be appropriate to apply, was determined. The lower limit on the radius of PA absorber was
determined based on practical experience. From simulation, we observed that if the absorber
radius was reduced below certain value then the corresponding slope of the best fit linear model
became negative. When we applied power spectrum analysis to the PA signals generated by
excised human prostate specimens, we did not observe negative slope value for any A-line PA
signal. Based on that observation, we decided that the appropriate lower limit for our system [88
µm] is the radius corresponding to the minimum positive slope.
Relation between the spectral parameters and mean absorber radius: Xu et al. [5.13] established
relations between dimension of the spherical absorbers and the spectral parameters for
microspheres with identical sizes. For real biological tissue, the dimensions of the absorbers are
expected to vary. In our study we investigated the relations using radii sampled from a given
Gaussian distribution with a specific mean radius. This along with the introduction of noise
similar to that present in our actual tissue PA data, made our simulation study close to the real
tissue situation. Instead of finding out relation among spectral parameters with individual
absorber radius values [5.13], we investigated relationship of different spectral parameters with
mean absorber radii and our findings were identical with that of Xu et al.
Resolving power of the power spectrum analysis: We investigated the minimum difference in
radius between two absorbers that can still give rise to distinguishing parameters using PA power
spectrum analysis. Two sample two tailed t test was used for this purpose. Within the appropriate
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radius range, we chose mean radii separated by specific distances [40 µm, 30 µm, 20 µm and 10
µm] and performed t test with the corresponding spectral parameters. We concluded that with
our PA imaging system, it is possible to differentiate between two separate spherical absorbers
using power spectrum analysis provided their radii are at least 30 µm apart.
In the experimental study performed with prostate specimens, using marked histology slides of
the prostate specimens as the ground truth, the spectral parameters corresponding to different
tissue types, i.e. malignant, BPH and normal prostate tissue were analyzed.
In statistical analysis, the two sample two tailed t test was performed for each spectral parameter
at each of the five wavelengths. For ease of discussion, spectral parameters at different
wavelengths are referred as different parameters. So, for each pair of different tissue types, two
sample two tailed t tests were performed for fifteen parameters [three spectral parameters at five
different wavelengths]. Results are presented for three pairs of tissue types; namely malignant vs.
normal prostate, malignant vs. BPH and BPH vs. normal prostate. For the analysis, we assumed
that when the p value was less than 0.05, the corresponding parameter would be significantly
different for the chosen tissue pair. Under this criterion, in the case of malignant vs. normal
prostate, thirteen out of fifteen parameters were significantly different. For malignant vs. BPH,
twelve out of fifteen parameters were significantly different while for BPH vs. normal prostate,
eleven out of fifteen parameters were significantly different. Since the primary focus of this
study was to differentiate malignant prostate tissue from other types of prostate tissue, a separate
tissue category called ―nonmalignant‖ prostate was created by combining all the normal as well
as BPH ROIs and statistical analysis was performed to determine the capability of the spectral
parameters for differentiating malignant ROIs from nonmalignant ROIs in prostate. In this case,
only one parameter out of fifteen failed to meet the abovementioned significance criterion. We
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also compared the performance of the three distinct spectral parameters [slope, midband fit and
intercept] for all the wavelength and tissue pairs. Performance of midband fit was the best
because for all the parameters the corresponding p values were well below the abovementioned
significance criterion. Next was the intercept followed by the slope parameter. From the
statistical analysis results, it is evident that frequency domain analysis is most effective in
differentiating malignant prostate from normal prostate while it is least effective in
differentiation BPH from normal prostate. When BPH and normal prostate ROIs were combined
as nonmalignant, frequency domain analysis was very efficient in differentiating malignant from
nonmalignant prostate.
We can discuss our results from a theoretical standpoint. Using Equation 5.17, PA power
spectrum in the dB scale can be written as
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To compute the spectral parameters, right hand side of Equation 5.19 was fitted to a straight line
and slope, intercept and midband fit were extracted from the straight line. It is evident that slope
only depends upon log[g(f)] as the remaining terms of Equation 5.19 are independent of
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frequency and thus slope is independent of absorption coefficient µa of the absorber. Intercept is
determined by the frequency independent terms i.e. log[µa] and log[r2]. Along with log[g(f)],
Midband fit also depends upon log[µa] and log[r2]. As slope is independent of the absorption
property and only depends upon the dimension of the absorber, it is generally regarded as the
most useful one among the three parameters for providing information about the size of the
absorber and consequently for differentiating between different tissue pathologies assuming
absorber size changes with tissue pathology. According to Equation 5.15, the peak intensity of
time dependent PA signal at any pixel location is generally considered to depend on absorption
coefficient of the tissue but independent of the absorber diameter. Therefore the midband fit and
intercept parameters may be regarded as superior to slope because of their combined dependence
on both absorption coefficient and absorber diameter through the terms log[µa] and log[r2].
Experimental PA data were acquired at five different wavelengths and the spectral parameters
were extracted at all of these five wavelengths. According to the results of statistical analysis,
considering the four pairs of different prostate tissue types, among the five wavelengths, 760 nm,
800 nm and 850 nm are the three effective wavelengths at which the spectral parameters are
better suited to differentiate between separate prostate tissue types than the other two
wavelengths. As mentioned previously, the idea behind performing multiwavelength PA imaging
was to exploit the wavelength dependent optical absorption property of the tissue for
investigating the difference between different types of prostate tissue. Slope is expected not to
change with wavelength as it is independent of wavelength dependent optical absorption
property of the absorber. From Figure 5.18A and 5.19A, it can be seen that for all types of
prostate tissue, change in corresponding mean slope value with the change of wavelength is
small [within 0.5dB/MHz]. Except 800 nm, for all tissue types, mean values of midband fit and
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intercept decrease with increasing wavelength. If we assume that deoxyhemoglobin is the
primary chromophore present in the tissue specimens, then the decreasing specific absorption
coefficient of deoxyhemoglobin with increasing wavelength in the 700 nm -1000 nm wavelength
range explains the decreasing trend of mean midband fit and mean intercept with increasing
wavelength.
So, in conclusion, we can say that the simulation study demonstrates the capability of power
spectrum analysis of PA signal for our limited bandwidth PA acquisition system whereas the
results of experimental study establishes that the spectral parameters extracted from 3D PA data
generated by freshly excised human prostates, can differentiate malignant prostate tissue from
BPH as well as normal prostate tissue.
5.2.5 Thyroid Specimens Results
The mean values of the three spectral parameters corresponding to three different types of ROIs
were plotted against the wavelengths in Figure 5.21. The mean values were computed over the
respective number of ROIs that were included into the study corresponding to cancer, benign and
normal thyroid tissue. At each point of all the plots, the error bar and the circle represent the
standard deviation and median value of the corresponding parameter over the respective number
of ROIs. The ROIs corresponding to benign and normal thyroid tissue were grouped into
‗nonmalignant‘ category and the mean values of the three parameters corresponding to
nonmalignant and malignant thyroid ROIs were plotted against wavelengths in Figure 5.22.
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Figure 5.21: Plot of average values of the three parameters corresponding to different ROIs
against five different wavelengths (A) Mean slope vs. wavelength (B) Mean midband fit vs.
wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the standard
deviation of the corresponding parameter over the respective number of ROIs. Circles represent
median values of the parameters.

Figure 5.22: Plot of average values of the three parameters corresponding to nonmalignant and
malignant ROIs against five different wavelengths. (A) Mean slope vs. wavelength (B) Mean
midband fit vs. wavelength; (C) Mean intercept vs. wavelength. The error bar at each point is the
standard deviation of the corresponding parameter over the respective number of ROIs. Circles
represent median values of the parameters.
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Two sample two tailed t-test was performed with the parameter values to find out whether there
was statistically significant difference between the parameters corresponding to ROIs of different
types. Figure 5.23 shows the results of the t-test performed at 5 % significant level with the
values of three parameters corresponding to malignant vs. normal, malignant vs. benign, benign
vs. normal and malignant vs. nonmalignant thyroid tissue.

Figure 5.23: Comparison of spectral parameters between different thyroid tissue types (A)
malignant vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs.
nonmalignant using two sample two tailed t-test. The red lines show the levels corresponding to
decision criterion (p = 0.05).
From Figure 5.23, it can be seen that between malignant and normal thyroid tissue, while
midband fit and intercept are significantly different (p<0.05) for all the five wavelengths, besides
at 800 nm, slope is not significantly different (p>0.05) for the other four wavelengths. Between
malignant and benign thyroid, midband fit and intercept are significantly different (p<0.05) but
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besides at 760 nm, slope at all of the four other wavelengths are not significantly different
(p>0.05). Between benign and normal thyroid all three spectral parameters at 970 nm and
intercept at 760 nm and 970 nm are not significantly different (p>0.05). For malignant vs.
nonmalignant thyroid slope values at five wavelengths are not significantly different while
midband fit and intercept are significantly different (p<0.05).
5.3 Spectral Centroid
Spectral centroid a time dependent signal p(t) can be computed using Equation 5.20
N

Spectral Centroid 

 fS ( f )
f 1
N

 S( f )

5.20

f 1

Here f represents frequency, S(f) is the Fourier transform of the time dependent signal p(t) and N
is the total no of samples.
Spectral centroids of the PA A-line signals corresponding to the identified ROIs in 3D PA data
were computed using Equation 5.20.
5.3.1 Prostate Specimen Results
Two sample two tailed t-test was performed with the spectral centroid values extracted from the
ROIs in 3D PA datasets to find out whether there was statistically significant difference between
spectral centroid values corresponding to ROIs of different types. Figure 5.24 shows the results
of the t-test performed at 5 % significant level with the values of the parameter corresponding to
malignant vs. normal, malignant vs. BPH, BPH vs. normal and malignant vs. nonmalignant. The
ROIs corresponding to BPH and normal prostate tissue are grouped into the ‗nonmalignant‘
category.
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Figure 5.24: Comparison of spectral centroid between different prostate tissue types (A)
malignant vs. normal (B) malignant vs. BPH (C) BPH vs. normal (D) malignant vs.
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding
to decision criterion (p = 0.05).
From Figure 5.24, it can be seen that between malignant and normal prostate tissue, the spectral
centroid values were significantly different (p<0.05) at all of the five wavelengths except 930
nm. Between malignant and BPH prostate, besides 800 nm and 850 nm, spectral centroid values
were significantly different (p<0.05) at the other wavelengths. For BPH vs. normal prostate,
spectral centroid value was not significantly different (p>0.05) only at 800 nm. For malignant vs.
nonmalignant prostate tissue, spectral centroid was significantly different (p<0.05) at 760 nm and
850 nm.
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Two way ANOVA test was performed with the spectral centroid values considering tissue
category and wavelengths as two predictors. Tissue category contains three separate groups of
tissue namely cancer, benign and normal, while wavelength consists of 760 nm, 800 nm, 850 nm,
930 nm and 970 nm.
Table 5.4: Two way ANOVA test results for spectral centroid values between different tissue
types and wavelengths.
Source

Sum

Degrees of Mean

F

Prob>F

Square

Freedom

Square

Tissue category

61.86

2

30.9307

32.23

1.3023e-14

Wavelength

210.69

4

52.6724

54.88

4.05942e-45

Tissue

51.27

8

6.4083

6.68

1.0296e-08

Error

3858.22

4020

0.9598

Total

4242.04

4034

category*chromophore

Results of the two way ANOVA test shows that means of spectral centroid values are
significantly different between different tissue types as the corresponding p value is very small
[1e-14] and spectral centroid means are also significantly different between different PA
wavelengths [p value = 4e-45]. As the p value corresponding to interaction term is very small
[1e-08], the effects of wavelengths and tissue types depend on each other.
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5.3.2 Thyroid Specimen Results
Two sample two tailed t-test was performed with the spectral centroid values extracted from the
PA ROIs corresponding to different types of thyroid tissue to find out whether there was
statistically significant difference between spectral centroid values corresponding to different
thyroid tissue types. Figure 5.25 shows the results of the t-test performed at 5 % significant level
with the values of the parameter corresponding to malignant vs. normal, malignant vs. benign,
benign vs. normal and malignant vs. nonmalignant thyroid tissue. The ROIs corresponding to
benign and normal thyroid tissue are grouped into the ‗nonmalignant‘ category.

Figure 5.25: Comparison of spectral centroid between different thyroid tissue types (A)
malignant vs. normal (B) malignant vs. benign (C) benign vs. normal (D) malignant vs.
nonmalignant using two sample two tailed t-test. The dashed lines show the levels corresponding
to decision criterion (p = 0.05).
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From Figure 5.25, it can be seen that between malignant and normal thyroid tissue, the spectral
centroid values are significantly different (p<0.05) at all of the five different wavelengths.
Between malignant and benign thyroid, besides 760 nm, spectral centroid values are significantly
different (p<0.05) at the other wavelengths. For benign vs. normal thyroid, spectral centroid
value is not significantly different (p>0.05) only at 970 nm. For malignant vs. nonmalignant
thyroid tissue, spectral centroid is significantly different (p<0.05) at the five wavelengths.
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CHPATER 6: Computer Aided Diagnosis Using Extracted PA Features
6.1 Computer Aided Diagnosis (CAD)
Conventional decision making method for prostate cancer diagnosis and management involves
basic analysis of a combination of a few markers by a radiologist. Radiologists, being human
beings, cannot process and analyze large number of markers for making the decision which may,
sometime produce inferior decisions. On the other hand, computer based decision making
models or classifiers like artificial neural network (ANN) or support vector machine (SVM) can
perform multivariate analysis and model nonlinear relationships between inputs and outputs.
CAD is gradually becoming popular for prostate cancer detection, staging and management.
In Chapter 4 & Chapter 5, several features were extracted from the multiwavelength 3D PA data
of excised prostate specimens and statistical analysis were performed to test whether the
extracted features were significantly different between different tissue pathologies. The next step
would be to test the capability of the extracted features to identify or predict a particular tissue
pathology using a suitable classifier model.
6.2 Literature Review of CAD of Prostate cancer
Lee et al. compared the performances of decision models based on logistic regression, SVM and
ANN classifiers for predicting outcome of prostate biopsy of actual human patients using input
data consisting of age, DRE findings, PSA information and TRUS findings and for their study,
performance of SVM was best among the three classifiers [6.1]. Using tumor stage, PSA
information, Gleason score and age as input variables, Botoca et al. observed that ANN
performed better that logistic regression to predict prostatic capsule penetration for their study
[6.2]. Using age and radioimmunometric serum PSA concentration as input variables, Chiu et al.
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applied an ANN model to predict skeletal matastasis in patients with prostate cancer [6.3].
Saritas et al. devised an ANN model to predict whether a patient has prostate cancer or not using
free PSA, total PSA and age information and the outcome of the model can eventually help the
doctor to take the decision whether or not to conduct the biopsy [6.4]. Cinar et al. implemented
SVM and ANN classifiers for early diagnosis of prostate cancer using prostate volume, PSA,
density and age information as input variables [6.5]. Kawakami et al. have compared the
performances of logistic regression based models with that of ANN based models for predicting
prostate cancers in patients using age, DRE information, PSA information, prostate volume and
TRUS findings [6.6]. Using clinical TNM classifications, Gleason scores, PSA information,
TRUS findings and MRI findings as input variables, Polakis et al. compared the performances of
the ANN based models and regression based models for predicting biochemical recurrence after
radical prostatectomy [6.7]. Using SVM classifiers, Moradi et al. compared the performances of
different types of features extracted from RF US time series data for predicting prostate cancer in
an ex-vivo study [6.8]. Using ANN classifier trained by features extracted from RF US signal
and PSA information, Fellepa et al. computed cancer likelihood score at each pixel and generated
greyscale images displaying scores at each pixels [6.9]. Alqasemi et al. compared the
performances of generalized regression model, SVM and ANN to predict ovarian cancer using
features extracted from coregistered UA and PA images of ex vivo ovarian specimens [6.10].
6.3 Building Multidimensional Feature Space
Multiwavelength 3D PA images of 30 excised prostate specimens were acquired at our
laboratory. Using marked histology images as ground truth, ROIs corresponding to malignant,
benign and normal prostate tissue were identified in the 3D PA images. Each ROI contains
multiple PA A-line signals generated by a specific type (normal, benign or malignant) of prostate
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tissue. We assumed each PA A-line signal contains characteristics of the particular tissue type to
which it belongs and so rather than extracting features from individual ROIs, we extracted
features from individual PA A-line signals. Total number of input feature vectors is 807 among
which 398 vectors belong to malignant prostate while the rest belong to nonmalignant prostate
[normal - 276, BPH - 133]. Since the primary objective of this study was to detect malignant
prostate tissue, here only two classes namely malignant and nonmalignant were considered.
The extracted features from 3D PA images can be divided into three different categories
representing different optical and physiological properties of the tissue specimens. The three
categories are;
A. PA pixel values [Grayscale pixel values of 2D C scan PA images formed from acquired 3D
PA data] - 5.
B. Chromophore concentrations

[Spatially varying concentrations

of four different

chromophores, computed using the multiwavelength PA pixel values].
C. Frequency parameters [Slope, midband fit and intercept values and spectral centroid of each
PA A-line at five different wavelengths] – 20.
Combining all the features together, a 29 dimensional input feature space was built.
6.4 ANN
The aim of the classification algorithms is to assign an input vector x to one of the K distinct and
disjoint classes. In supervised classification, a large dataset is used to train the parameters of an
adaptive model or classifier exploiting the prior knowledge of each of the input vector‘s
corresponding category. Once training has been done, input vectors belonging to a new dataset,
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known as testing dataset, is used to test the ability of the classifier to correctly categorize input
data which does not have any overlap with training dataset. An appropriate function y(x) can be
formed to represent the classifier or the adaptive model. The value of y(x) corresponding to the
input vector x represents the value of the target variable t. For two class problem, t can be a
scalar variable which can be used to represent either of the class labels. For more than two class
problem, t has to be a vector variable whose number of elements is equal to the number of
classes and each element is designated to represent a specific class label.
A simple generalized linear model used for a two class problem can be expressed as



y( x, w)  f wT x  w0



6.1

Where x = (x1, x2, …… xN)T is the input vector in the N dimensional input space, w = (w1, w2,
……..wN)T is the parameter vector, w0 is the bias parameter and f(.) is the nonlinear activation
function used specially for the classification purpose. To make the model more generalized, x
can be replaced by a fixed nonlinear function υ(x) known as basis function of x. Then Equation
6.1 can be written as

 M 1

y( x, w)  f   w j j x   w0  
 j 0


M

f   w j j x 
 j 0


6.2

Here υ = (υ1,……υM)T and υ0(x) = 1.
Artificial Neural Network (ANN) is a computer generated information processing system which
is motivated by the function of biological nervous systems such as animal brain. An ANN has a
number of processors or ―units‖ which are interconnected by ―links‖ or ―connections‖. This
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network of units can work together in a distributive manner to learn from input information and
discover new information.
The most commonly used ANN has three layers, namely input, hidden and output. Each layer
contains a number of nodes or neurons which are interconnected by links. Each link has its own
weight over which the signal is transferred from one node to another. Every node receives
information from a number of other nodes and produce output that depends on the combination
of received information.
An ANN uses basis functions each of which is a nonlinear function of the linear combination of
the components of input vector. As the basis functions depend upon the parameters used for
combining the input vector components, these parameters as well as the parameter vectors w in
Equation 6.2 are adjusted during training. So, the most commonly used ANN model can be
represented by the following equation.

M

 N

y k ( x, w)   k   wkj h  w ji xi w j 0   wk 0 
 i 1

 j 1


6.3

Here yk represents the value of the model at kth output and σk is the activation function at the kth
output node.
Now, to obtain Equation 6.3, each layer has to be considered sequentially i.e. starting from the
input layer we need to move forward until output layer is reached. Here, we have only
considered feed-forward architecture where the information progresses in the forward direction
via the network. If we consider N dimensional input space, then the input layer will contain N
nodes. Linear combination of the input variables, applied at the input nodes can be represented
by Equation 6.4
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N

ah j   w ji xi w j 0

6.4

i 1

Here the subscript j represents a particular node (jth) in the hidden layer and the wji is the weight
corresponding to the link which connects jth node in the hidden layer to ith node in the input layer.
The bias parameter connected to the jth node in the hidden layer is wj0 while ahj is the linear
combination of the nodes in input layer. Now if hj is considered to be the nonlinear activation
function for the jth node, then
z j  h j (ah j )

6.5

Where zj is the ouput of the jth hidden node. Now if the hidden layer is M dimensional i.e. if it
contains M nodes in total, then the linear combination of the outputs of all the hidden nodes at kth
node in the output layer can be expressed as
M

aok   wkj z j wk 0

6.6

j 1

Now if the activation function for each output node is σ, then

yk   k (aok )

6.7

Combining Equation 6.4, 6.5, 6.6 & 6.7 we obtain Equation 6.3.
During training, using the input training vectors and the corresponding target variables, the set of
parameter vectors or weights associated with different links in the ANN are adjusted to minimize
a particular error function. The type of error function is chosen depending upon the particular
problem. One commonly used error function is mean square error (MSE) defined by Equation
6.8.
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 yk xn , w  t kn
KN n1 k 1

2

6.8

Here tkn represents the value of the target variable at kth output node for input xn and yk
represents the model output at kth output node for xn. The particular set of w parameters or the
weight vectors which yields the minimum E, is determined during training of ANN. Now the
minimum points of the error function can be located efficiently by computing the gradient of the
error function ∇E, as ∇E points the direction of greatest increase of error.
The gradient of error function is computed by using a method known as error backpropagation in
which information is sent forward and backward alternately through the ANN. Generally, during
training of ANN, minimization of the error function is achieved via an iterative process using a
sequence of steps. Each such step can be divided into two separate stages. In stage one,
derivatives of the error function [gradient, jacobian or heissian of the error function] with respect
to weights are computed using backpropagation algorithm. Then in the next stage the computed
derivatives are used by a suitable optimization scheme to adjust or update the weight vectors
until the minimum error points are reached. In batch methods, the complete dataset is used at
once whereas the online methods adjust weight vector using one data point at a time [6.11].
Application of ANN on the actual data
The ANN used in this study, was built and executed using MATLAB Neural Network toolbox.
Here a feed forward ANN was used. The ANN had one input layer, one hidden layer and one
output layer. Number of nodes in the input layer was equal to the dimension of the input feature
space [29 for the combination of all extracted features] while hidden layer and the output layer
had 10 and 2 nodes respectively. Before applying it to the input of the network, the complete
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dataset [807 x 29] was scaled in the range of -1 to 1 using the ‗mapminmax‘ function available in
the NN toolbox. The ‗mapminmax‘ function uses the Equation 6.9 to scale the data

 x  xmin
xscale  2
 xmax  xmin


  1


6.9

The whole dataset was divided into training set and testing set such that the ratio of train strength
[number of training set members]: test strength [number of testing set members] was 60:40. The
assignment of data members to training and testing data sets was completely random. The ANN
was trained with the training set using ‗trainlm‘ function in the NN toolbox. The ‗trainlm‘
function calculates the jacobian of the performance/error metric with respect to weight and bias
vectors at each step and then implements Levenberg-Marquardt optimization to adjust the weight
and bias vectors. The network architecture was trained with the training data for 10 times. For
each session, the training started with different sets of initial values of weights and biases. In
each session, after training was complete, the performance of the network was tested with the
testing dataset by measuring the MSE using Equation 6.8. The trained network which yielded the
best performance i.e. the lowest MSE for the testing set, was selected as the optimum network
and the corresponding classification results were saved. The complete process [starting from the
random division of training and testing datasets] was performed 50 times to be certain about the
network performance. The mean, median and standard deviation of sensitivity and specificity
obtained with training and testing data set have been reported in results. The transfer function
used in the hidden layer was ‗tansig‘ and in the output layer ‗softmax‘. Equation 6.10 and 6.11
describe the ‗tansig‘ and ‗softmax‘ algorithms.

tan sig ( z ) 

2
1
1  exp  2 z 

6.10
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soft max( z ) 

exp( z )
sum[exp( z )]

6.11

After the ANN was used to classify the malignant and nonmalignant prostate tissue using the
complete feature space, similar network architechture [same number of layers and nodes] was
employed to determine which category of the features were most efficient in predicting prostate
cancer. Input data consisting of only multiwavelength PA pixels [5 dimensional feature space],
spatially varying chromophore concentrations [4 dimensional feature space] frequency
parameters [20 dimensional feature space] and a combination of PA pixels and chromophore
concentrations [9 dimensional feature space] were used to train and test ANN classifiers in the
exact same manner as described earlier.
6.5 SVM:
The linear discriminant function for the two class classification problem can be expressed as
y( x)  wT  ( x)  w0

6.12

Where y is the output of the model, x is the input vector, w and w0 are the weight vector and the
bias and υ(x) is the basis function. Let the training data [considering supervised classification]
comprises of N input vectors with corresponding target values represented by t n [tn can only be 0
or 1]. If we assume that the training data are linearly separable in the basis function space, then w
and w0 can be evaluated using training dataset. Any new input vector will be correctly classified
if its corresponding target variable tn =1 and the model output y(x)>0, or if tn = 0 and y(x)<0
where y(x) = 0,represents the decision boundary in basis space.
A support vector machine (SVM) selects the decision boundary corresponding to maximum
margin. The margin is defined as the smallest distance between any correctly classified training
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data point and the decision boundary. The perpendicular distance between a data point x n and the
decision boundary is

y( xn ) wT  ( xn )  w0

w
w

6.13

As for correctly classified data points tny>0, so the expression for margin can be written as





t n y( xn ) t n wT  ( xn )  w0

0
w
w

6.14

The parameters w and w0 need to be optimized to find out the maximum margin solution. The
maximum margin optimization problem can be written as

 1
arg max  min t n wT  ( xn )  w0
w, w0
 w n





6.15



With proper scaling, for a correctly classified training data point xn which is also the nearest data
point to the decision boundary, Equation 6.16 can be written.





t n wT  ( xn )  w0  1

6.16

As maximizing 1/||w|| is equivalent to minimizing ||w||2, so considering all of the correctly
classified training data points, the optimization problem can be rewritten as following

arg min
w, w0

1 2
w subjected to the constraints t n wT  ( xn )  w0   1
2

6.17

The Lagrange function for the optimization problem can be written as
1
Lw, w0 , a  

2

N



 

w   an t n wT  ( xn )  w0  1
2

6.18

n 1

Where a = (a1,a2,……..an)T is the set of Lagrange multipliers, one for each constrain in Equation
6.17.
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Differentiating Equation 6.18 with respect to w, w0 and equating the results with zero, Equations
6.19 and 6.20 are obtained.
N

w   an t n xn 
n 1

6.19

N

0   an t n
n 1

6.20

Combining Equation 6.18, 6.19 and 6.20, the optimization problem can be converted into the
following dual representation problem where Ld is maximized.
N

Ld a    an 
n 1

1 N N
 an amt nt m k xn , xm 
2 n1 m1

6.21

Here Ld is maximized with respect to dual variable a subjected to the following constraints.
N

0   an t n
n 1

an  0

6.22

The above maximization problem is solved to find out the Lagrange multipliers a = (a1,
a2…………an)T during training.
After training, any new data point or member of the testing set is classified according to the sign
of y(x) in Equation 6.23.
N

y ( x)   an t n k x, xn   w0

6.23

n 1

As a constrained optimization problem satisfies Karush-Kuhn-Tucker conditions [6.11], so
an  0
t n y  xn   1  0

an t n yxn   1  0

6.24
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So, for every data point in the training set either an = 0 or tny(xn) = 1. Now the points for which
an = 0, do not contribute anything to Equation 6.24. So, the contributing data points are those for
which tny(xn) = 1. As these points lie on the maximum margin hyperplane, they are known as
support vectors. Once the support vectors and the Lagrange multipliers are found, the bias
parameter w0 can be computed using Equation 6.25.

w0 

1
Ns



  t   a
ns

n

ms


t k  x n , x m 


m m

6.25

The above Equations have been derived based on the assumption that the training dataset is
linearly separable in the basis function space. Similar Equations can also be derived for
overlapping class conditional distribution which is more practical [6.11] .
Application of SVM to the prostate PA data:
For building and executing SVM classifiers, a python based machine learning toolkit named
‗scikit-learn‘ was used [6.12]. As mentioned earlier for the ANN classifier, the number of input
vectors was 807 while the dimension of the feature space was 29. The complete input dataset
was scaled in the range 0 to 1. Using 60% of the dataset a training set was formed and the rest
was used to form the testing set. The assignment of feature vectors to training and testing sets
was completely random. We worked with polynomial and Gaussian radial basis function [RBF]
kernel types to select the kernel with best performance. We performed exhaustive searches in the
parameter space to find out the appropriate values of the hyperparameters [C and γ for RBF, C
for polynomial of order 3] as well as the appropriate type of kernel function. For each set of
parameter and each kernel type, fivefold cross validation was performed. RBF kernel with C =
100 and γ = 1.5 yielded the best performance for classifying malignant and nonmalignant
prostate tissue.
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6.6 Results & Discussions
Classification Metrics
Confusion matrix: It tabulates the performance of a supervised learning classifier in a matrix
form where each row represents the instances of actual classes and each column represents the
instances of predicted classes.
Table 6.1: Confusion matrix

Predicted Class

Malignant

Nonmalignant

Malignant

True Positive [TP]

False Negative [FN]

Non-malignant

False Positive [FP]

True Negative [TN]

Actual
Class

Table 6.1 shows the example of the confusion matrix which tabulates the performance of a
classifier predicting malignant and nonmalignant tumors. For a given classifier and an instance
(input feature vector), there can be four possible outcomes. If the instance actually belongs to
malignant category and the classifier also predicts it as malignant, then it will be counted as
‗True Positive (TP)‘. Similarly if the instance is nonmalignant and the prediction by the classifier
is also nonmalignant, then it will be counted as ‗True Negative (TN)‘. On the other hand if the
instance actually belongs to malignant category but the classifier labels it as nonmalignant then
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that will be marked as ‗False Negative (FN)‘. Similarly, if the instance is nonmalignant and the
classifier labels it as malignant then that will be marked as ‗False Positive (FP)‘. Using the
number of TP, TN, FP and FN, following classification metrics can be computed.
Sensitivity or Hit rate or Recall or True Positive Rate (TPR) = TP/ [TP + FN].
Specificity = TN/ [FP + TN].
Precision or Positive Predictive value [PPV] = TP/ [TP + FP].
Negative Predictive value [NPV] = TN/ [TN + FN].
False Positive Rate [FPR] = 1- Specificity = FP/ [FP + TN].
For our data, malignant represents positive class and nonmalignant represents negative class.
Receiver Operating Characteristics (ROC) curve: A ROC graph is obtained by plotting
sensitivity or TPR vs FPR or 1-specificity for different values of threshold. It shows the relative
tradeoff between profit i.e. TP and cost i.e. FP. The point (0, 1) represents perfect classification.
The point (0, 0) corresponds to zero false positives and zero true positive while the point (1, 1)
represents unconditional positive classification. The diagonal line with unit slope in the ROC
graph represents the results of random guessing [6.13]. For example, if a classifier guesses
randomly positive outcome 80% of the time then one can expect it to predict 80% of the
positives correctly, but at the same time the false positive rate will also increase to 0.8 and thus
the corresponding point in the ROC space will be (0.8, 0.8).
Area under Receiver Operating Characteristics curve (AUROC): The Area under ROC graph
represents the probability that the corresponding classifier will rank a randomly chosen positive
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outcome higher than the randomly chosen negative outcome [6.13]. This metric is generally used
to compare the performance of different classifiers used for the same purpose.
SVM Classifier Results:
Input dataset: 807 x 29
Train data: Test data = 60:40.
Kernel used: RBF [C = 100, γ = 1.5].
Table: 6.2 Classification Results with SVM on the complete dataset
Training data

Testing Data

Sensitivity

0.98

0.84

Specificity

0.98

0.91

Precision

0.98

0.90

NPV

0.98

0.86

Accuracy

0.98

0.88
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Figure 6.1: ROC for SVM Classifier with test data.
Figure 6.1 shows the ROC graph for the SVM classifier applied to our dataset for detecting
prostate cancer. The AUROC is 0.96.
ANN Classifier Results:
A. Using the complete 29 dimensional feature space.
Input dataset: 807 x 29
Train data: Test data = 60:40.
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Table 6.3: Classification Results with ANN on the complete dataset. Here Mean, Std. dev
[standard deviation] and Min [minimum] are the mean, standard deviation and minimum of the
results obtained in 50 iterations.
Training data
Sensitivity

Mean = 0.97, Std. dev = 0.014, Min = Mean = 0.93, Std. dev = 0.02, Min =
0.92

Specificity

Testing Data

0.88

Mean = 0.96, Std. dev = 0.02, Min = Mean = 0.91, Std. dev = 0.03, Min =
0.89

0.86

Precision

Mean = 0.96

Mean = 0.92

NPV

Mean = 0.97

Mean = 0.93

Accuracy

Mean = 0.97

Mean = 0.91
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Figure 6.2: ROC for ANN Classifier with test data [29 dimensional]
Figure 6.2 shows the ROC graph for the ANN classifier applied to our dataset [29 dimensional]
for detecting prostate cancer. The AUROC is 0.99. For plotting the ROC curve, we selected the
best results i.e. which correspond to highest accuracy out of 50 iterations.
Comparing the performance of ANN and SVM for predicting malignant prostate tissue using 29
dimensional input data, it can be concluded that ANN performed better that SVM as the AUROC
for cancer detection in case of ANN is higher [0.99] than that of SVM [0.96]. Also both of
sensitivity and accuracy of ANN with test data [0.93 and 0.91] are higher than those of SVM
[0.84 and 0.88]. Performance of both SVM and ANN test data are found to be satisfactory.
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B. Using only the multiwavelength PA pixel values.
Input dataset: 807 x 5
Train data: Test data = 60:40.
Table 6.4: Classification Results with ANN on the subset containing only the multiwavelength
PA pixels. Here Mean, Std. dev [standard deviation] and Min [minimum] are the mean, standard
deviation and minimum of the results obtained in 50 iterations.
Training data
Sensitivity

Mean = 0.81, Std. dev = 0.05, Min = Mean = 0.78, Std. dev = 0.05, Min =
0.67

Specificity

Testing Data

0.66

Mean = 0.67, Std. dev = 0.07, Min = Mean = 0.63, Std. dev = 0.06, Min =
0.53

0.53

Precision

Mean = 0.72

Mean = 0.69

NPV

Mean = 0.77

Mean = 0.74

Accuracy

Mean = 0.74

Mean = 0.71
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Figure 6.3: ROC for ANN Classifier with test data [5 dimensional]
Figure 6.3 shows the ROC graph for the ANN classifier applied to a subset of data containing
only multiwavelength PA pixel values [5 dimensional] for detecting prostate cancer. The
AUROC is 0.85. For plotting the ROC curve, we selected the best results i.e. which correspond
to highest accuracy out of 50 iterations.
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C. Using only the chromophore concentrations.
Input dataset: 807 x 4
Train data: Test data = 60:40.
Table 6.5: Classification Results with ANN on the subset containing only the chromophore
concentrations. Here Mean, Std. dev [standard deviation] and Min [minimum] are the mean,
standard deviation and minimum of the results obtained in 50 iterations.
Training data
Sensitivity

Mean = 0.87, Std. dev = 0.02, Min = Mean = 0.85, Std. dev = 0.03, Min =
0.81

Specificity

Testing Data

0.76

Mean = 0.79, Std. dev = 0.03, Min = Mean = 0.77, Std. dev = 0.03, Min =
0.71

0.70

Precision

Mean = 0.81

Mean = 0.79

NPV

Mean = 0.86

Mean = 0.83

Accuracy

Mean = 0.83

Mean = 0.81
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Figure 6.4: ROC for ANN Classifier with test data [4 dimensional]
Figure 6.4 shows the ROC graph for the ANN classifier applied to a subset of data containing
only chromophore concentration values [4 dimensional] for detecting prostate cancer. The
AUROC is 0.91. For plotting the ROC curve, we selected the best results i.e. which correspond
to highest accuracy out of 50 iterations.
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D. Using only the frequency parameters [slope, midband fit, intercept extracted from power
spectrum analysis and spectral centroid. All were extracted for five different wavelengths].
Input dataset: 807 x 20
Train data: Test data = 60:40.
Table 6.6: Classification Results with ANN on the subset containing only the frequency
parameters. Here Mean, Std. dev [standard deviation] and Min [minimum] are the mean,
standard deviation and minimum of the results obtained in 50 iterations.
Training data
Sensitivity

Mean = 0.91, Std. dev = 0.03, Min = Mean = 0.85, Std. dev = 0.03, Min =
0.79

Specificity

Testing Data

0.79

Mean = 0.90, Std. dev = 0.04, Min = Mean = 0.84, Std. dev = 0.04, Min =
0.77

0.71

Precision

Mean = 0.90

Mean = 0.84

NPV

Mean = 0.90

Mean = 0.84

Accuracy

Mean = 0.90

Mean = 0.84
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Figure 6.5: ROC for ANN Classifier with test data [20 dimensional]
Figure 6.5 shows the ROC graph for the ANN classifier applied to a subset of data containing
only frequency parameter values [20 dimensional] for detecting prostate cancer. The AUROC is
0.96. For plotting the ROC curve, we selected the best results i.e. which correspond to highest
accuracy out of 50 iterations.
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E. Using the combination of multiwavelength PA pixels and chromophore concentration values.
Input dataset: 807 x 9
Train data: Test data = 60:40.
Table 6.7: Classification Results with ANN on the subset containing the multiwavelength PA
pixel values and chromophore concentrations. Here Mean, Std. dev [standard deviation] and Min
[minimum] are the mean, standard deviation and minimum of the results obtained in 50
iterations.
Training data
Sensitivity

Mean = 0.93, Std. dev = 0.02, Min = Mean = 0.90, Std. dev = 0.03, Min =
0.87

Specificity

Testing Data

0.83

Mean = 0.84, Std. dev = 0.05, Min = Mean = 0.80, Std. dev = 0.04, Min =
0.74

0.72

Precision

Mean = 0.85

Mean = 0.82

NPV

Mean = 0.92

Mean = 0.89

Accuracy

Mean = 0.88

Mean = 0.85
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Figure 6.6: ROC for ANN Classifier with test data [9 dimensional]
Figure 6.6 shows the ROC graph for the ANN classifier applied to a subset of data containing
multiwavelength PA pixel values and chromophore concentrations [9 dimensional] for detecting
prostate cancer. The AUROC is 0.96. For plotting the ROC curve, we selected the best results
i.e. which correspond to highest accuracy out of 50 iterations.
Comparing the performances of the ANN classifier using features of different categories, it can
be concluded that Frequency parameters performed best for detecting malignant prostate tissue
as the corresponding AUROC is the highest. Its performance is similar to the performance of the
combination of PA pixels and chromophore concentrations.
Generally researchers concentrate on recovering chromophore concentration from the PA images
as chromophore concentration provide direct physiological information about the tissue which
can be utilized to detect tissue abnormality. The results of this study shows that frequency
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parameters also can be used with significant efficiency for identifying tissue abnormality.
Although, the frequency parameters do not provide any functional information about the tissue
directly like chromophore concentration, but since midband fit and intercept parameter depend
partially on the amount of light absorbed by the tissue, so there may exist some indirect
nonlinear relationship between multiwavelength midband fit and intercept parameters with
chromophore concentration. We established in Chapter 5 that midband fit and intercept depend
both on optical properties and dimension of PA absorber. Since slope depends on the absorber
size only while the other two parameters depend on both size and optical property of tissue, so a
combination of these three parameters at multiple wavelengths may really be useful for tissue
characterization on their own.
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CHAPTER 7: Novel Ultrasound Imaging System
7.1 Dual Mode PA and US Imaging System
As mentioned earlier, PA signals map optical absorption property of the tissue. Either the
grayscale [B scan or C scan] PA images or different parametric images [e.g. chromophore
concentration, frequency parameters] formed using the PA signals, can be used to detect
particular tissue pathologies. But, the grayscale or parametric images do not bear any structural
information of the tissue or in other words they cannot localize the particular tissue pathologies
they are detecting. For diagnosis and treatment of cancer, localization of the cancer lesions is
very important. For example, while performing needle biopsy to diagnose prostate cancer, if the
detected lesion can be localized clearly, then direct sampling can be performed rather than
sampling the complete gland and that will reduce diagnosis uncertainty and physical discomfort
of the patient. As the bulk modulus variation based contrast is small in soft tissue, US imaging
has low accuracy in detecting cancer lesions. But it can reveal structural information like
boundary of a complete organ or presence of other nearby organs. For prostate, TRUS can depict
the important anatomical structures like urethra, bladder, prostate capsule etc. which can be used
as important cues to localize a detected cancer lesion during needle biopsy. So, if coregistered
PA and US image of the same organ can be fused together, then the fused image can potentially
detect and localize particular tissue pathology with high accuracy. For prostate cancer diagnosis,
a dual mode TRUS and PA imaging probe will be of critical significance as it can potentially
reduce the number of sample cores significantly, encourage targeted biopsy and also play a
critical role in monitoring the status of the tumor after treatment. Since both US and PA imaging
share the same receiving technology, so the receiver of the dual mode imaging system can be the
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same which makes it possible to produce coregistered PA and US images without the help of any
fiduciary markers.
7.1.1 Literature Review
Several research groups have built dual mode PA and US imaging systems. The dual mode
imaging systems have been built either by suitable modification of the existing commercially
available diagnostic ultrasound scanners [7.1 – 7.4] or using the same US transducer system
[single element transducer or transducer array] both for PA and US imaging along with the laser
source and suitable electronics in the laboratory setup [7.5 – 7.7].
In this study, we developed a novel pulse echo US imaging system which can be easily
integrated with our existing ex-vivo PA imaging system to produce the dual mode imaging
system. In the US imaging system, two different ultrasound transducer assemblies were used to
transmit and receive the US wave. A Polyvinylidene fluoride (PVDF) film transducer was used
as the source transducer. The PVDF transducer generates plane US wave. The US wave are
backscattered by the object and the backscattered wave get focused by a spherical acoustic lens
on to a linear array of transducers. To improve the anticipated low SNR of the received US
signal due to the low electromechanical coupling coefficient of the PVDF film, we implemented
pulse compression technique using linear frequency modulated (FM) signals or chirp signals.
7.2 Acoustics Lens Based Focusing
To improve the lateral resolution of the US B-scan images, various focusing technologies can be
implemented. Focusing with single element transducer can be achieved by spherically curving
the transducer or attaching an acoustic lens with the single element transducer [7.8]. A phased
transducer array can transmit US signal with curvature by electronically adding time delays to
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the excitation signals for different elements and can receive focused backscattered signal by
applying appropriate time delays to the elements during receiving. Although focusing at variable
depths can be achieved with the phased array transducer, it requires expensive dedicated
electronics [7.8, 7.9]. Also, for this process, each point in a certain cross-sectional object plane
has to be scanned separately. In this study, an acoustic lens focusing based imaging system is
explored. In this imaging system, focusing can be achieved by the acoustic lens and thus the
single element acoustic lens replaces the expensive and dedicated electronics that has to be used
if we employed phased arrays. To ensure that US plane wave was incident on the object, two
separate transducers were used here as source and receiver of the US wave. The acoustic lens
was placed in between the object and image plane in such a way that it was separated from both
the object and image plane by a certain distance. In this configuration, all points at a particular
cross-sectional object plane can be imaged at the same time at the corresponding image plane.
7.3 PVDF film as US Generator
A PVDF film transducer was used here as the plane wave generator. PVDF is a semicrystalline
polymer material with strong piezoelectric property [7.10]. Due to its wide bandwidth, low
acoustic impedance and high flexibility it is suitable for high frequency tissue imaging [7.11,
7.12]. Although it is not an ideal US transmitter due to its low electromechanical coupling
coefficient, it has very high receiving sensitivity [7.12, 7.13]. In this imaging system, the beam
axis of the source and receiver US transducers are on the same line and as it can be seen in
Figure 7.1, the backscattered US wave has to pass through the US source. The presence of the
source in the way of the backscattered US wave produces insertion loss. The acoustic impedance
of a PVDF film is an order of magnitude nearer to that of water than the acoustic impedance of a
conventional ceramic transducer material like Lead Zirconate Titanate (PZT) [7.13]. So the
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impedance mismatch between PVDF film and water is much lower than the impedance
mismatch between conventional ceramic transducer materials and water. This low impedance
mismatch reduces the insertion loss produced by the PVDF film compared to the insertion loss
that would be produced if PZT transducer was used. In addition to this, the lower thickness of the
PVDF film compared to a conventional ceramic transducer reduces the wavefront distortion of
the backscattered US wave [7.13].
7.4 Pulse Compression
As mentioned earlier, PVDF is not a good US transmitter. The electromechanical coupling
efficiency of PVDF is approximately three times lower than that of a PZT transducer [7.11,
7.13]. It was anticipated that, due to the low electromechanical coupling coefficient of PVDF
film, the amplitude of the input US plane wave might be low even after amplification. This low
amplitude input plane US wave would produce US images with low SNR. To improve the SNR
of the backscattered US wave, pulse compression technique using linear frequency modulated
signal was implemented here. Pulse compression using frequency modulated signal is a well
established technology. In conventional medical ultrasound imaging systems, it is used to
increase penetration depth and improve SNR deep inside the tissue [7.14 – 7.16]. The axial
resolution of an US imaging system improves with increasing frequency of the input US signal.
But at the same time, due to the frequency dependent attenuation property of the tissue, the
corresponding SNR degrades with increasing depth inside the tissue which in turn reduces the
penetration depth. Improving the SNR by increasing the peak intensity of the input signal is not a
solution as the peak intensity has to stay within the safety limit [7.14, 7.15]. Instead of using a
short pulse as in conventional pulse echo system, the pulse compression technique uses a long
duration frequency modulated signal as input, thereby distributing the total energy over the long
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duration input signal which reduces the peak intensity. After receiving, the backscattered signal
is fed to a matched filter which adjusts relative phases of the frequency components to produce
the compressed pulse with improved SNR [7.14, 7.15]. The time duration of the compressed
pulse is comparable to that of a conventional short pulse and thereby the axial resolution is
maintained.
Let us assume P(t) is the input FM wave and the backscattered wave S(t), is equal to sum of the
shifted and scaled replica of P(t) and uncorrelated noise n(t).
S (t )  P(t   )  n(t )

7.1

Where α is the scale factor and τ is the time shift of P(t). Now if S(t) is applied to a matched filter
with impulse response P*(-t) where P*(t) is the complex conjugate of P(t), then the compressed
pulse will be given by

S (t )  P (t )  P(t   ) * P (t )  n(t ) * P (t )   (t   )  P(t )  P(t )  n(t )  P(t )

7.2

Equation 7.2 tells us that the compressed pulse will be a scaled replica of the autocorrelation
function of P(t) at the shifted time coordinate τ [7.17]. Ideally, the noise n(t) is expected to be
uncorrelated to P(t), resulting P(t )  n(t )  0 . The  symbol represents correlation operation
whereas the  symbol represents convolution operation. A typical linear FM signal or chirp
signal can be expressed by Equation 7.3

P(t )  sin[2 {( f c  B)t 

B 2
t }] For 0< t < T0
T0

7.3

Here T0 is the time duration, 2B/ T0 is the linear frequency sweep rate and fc is the center
frequency of the chirp signal. The sweep bandwidth 2B of the chirp signal extends from (fc – B)
to (fc + B). Autocorrelation of P(t) results in a signal which is amplitude modulated by a sinc
function. The properties of the sinc function depend on the product of the time duration T0 and
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sweep bandwidth 2B, also known as the time bandwidth product [7.18]. Ideally, the
improvement of SNR after pulse compression is equal to the time bandwidth product of the input
FM signal [7.16]. It can also been shown that if the bandwidths of the input signals for
conventional short pulse and the linear FM signal are equal, then the axial resolution obtained for
both the cases are more or less equal [7.18].
The primary purpose of this work was to explore the feasibility of the novel acoustic lens
focusing based US imaging system and the use of a PVDF film transducer as US transmitter. The
PVDF film transducer was used here as the US plane wave generator to satisfy the requirement
of a US plane wave source so that echoes from all points in a given a depth plane, after being
focused by the acoustic lens, arrive at the US receiver almost at the same time. The secondary
purpose of this work was to explore the feasibility of implementing of pulse compression
technique in the above mentioned imaging system. The pulse compression technique is a wellestablished technique for SNR enhancement and it has been applied successfully to improve
SNR for several US medical imaging systems [7.14 – 7.16, 7.18]. In the proposed imaging
system, an acoustic lens was used as the focusing element. We suspected that the spherical
curvature of the lens might distort the quadratic phase modulation of the input chirp signal and
subsequently pulse compression might fail. So we wanted to test whether the pulse compression
technique could be implemented in presence of the acoustic lens. In the conventional pulse echo
system, the same transducer is used as the source and the receiver. So for that, the input pulse
duration must be less than the time taken by US wave to travel back and forth between the source
and the detector. No such constraint is there for our setup, as two different transducer assemblies
are used here as source and receiver. So for this set up, an input chirp pulse longer than usual can
be used to get a better SNR, as SNR improvement depends on the time bandwidth product of the
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input chirp. As this US system uses the same acoustic lens based focusing technology and a
similar linear transducer array used in our existing ex vivo PA imaging system, so it can be
easily integrated to our existing PA imaging system with minor modifications to acquire
coregistered PA and US images of the tissue sample.
7.5 Experimental Setup
Figure 7.1 describes the framework of the experiments performed in a water tank [7.19].

Figure 7.1: Experimental setup
In the above setup, the PVDF film transducer (Measurement Specialties: FDT1-028K 28μm
thick/ NDT1-220K 220μm thick) emits US plane wave (blue lines). Plane wave is emitted both
in the forward direction (towards the target) and reverse direction (towards the acoustic lens). In
Figure 7.1, plane wave emitted in forward direction is shown only. The plane wave was
backscattered by the target. The backscattered wave (red curves) propagated through the PVDF
film transducer to be focused by a custom designed acoustic lens (39.8 mm focal length, 32 mm
diameter) on to the linear array of ultrasound transducers (Olympus, center frequency: 5 MHz,
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12 dB bandwidth: 3MHz – 6.7 MHz, element count:16, pitch: 0.7 mm ). To obtain a
magnification of -1 between the image plane and the object plane, the object distance i.e. the
distance between the target and the acoustic lens and the image distance i.e. the distance between
the acoustic lens and the transducer array were kept equal to twice the focal length of the
acoustic lens. The distance between the target and the PVDF film was maintained to be within
the ‗nearfield region‘, determined by the aperture of the PVDF film and the peak wavelength of
the input signal driving the PVDF, to ensure that the incident wave on the target remained plane
wave. The US signal received by the linear transducer array was amplified by the amplifier. The
amplified US signal was digitized and stored in oscilloscope (Lecroy, WaveRunner 6030). Bscan images were formed using the stored A-line US signals in the oscilloscope. The US images
can be directly produced from the acquired data by this setup without any type of receiver beam
forming or electronic focusing algorithm. Depending on the configuration of the switch, the
PVDF film was driven either by the pulser (JSR Ultrasonics, DPR 300) to produce a short pulse
similar to that used in the conventional US pulse echo imaging or by the combination of signal
generator (Analogic, Polynomial Waveform Synthesizer 2020) and power amplifier (Electronics
& Innovation, A150) to produce amplified linear FM signal. To enhance the SNR of the
backscattered US signal, pulse compression technique was implemented in the above
experimental set up. The PVDF film transducer was driven by amplified chirp signal with long
time duration (>10μs) and pulse compression technique was performed in post-processing step
by cross-correlating the backscattered signal stored in the oscilloscope with input chirp signal.
As mentioned earlier, the SNR of the compressed pulse is expected to be greater than the SNR of
the backscattered chirp signal by the time bandwidth product of the input chirp signal.
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Following experiments were performed with the above mentioned imaging system


Several US A-line signals were acquired with short duration pulses of different peak to
peak voltages for a plane reflector target (Aluminum plate) at the object plane. With the
same target, US A-line signals under chirp excitation with the same set of peak to peak
amplitudes were also acquired.



Two dimensional (2D) point spread function (PSF) of the imaging system was measured
using a steel wire (0.4 mm diameter) as target in the water tank. Variation of SNR with
the time-bandwidth product and variation of axial resolution (6dB width along Z axis)
and lateral resolution (6 dB width along X axis) with the sweep bandwidth of the chirp
signals have been studied.



The above experiments were repeated with three different PVDF films of different
thickness. Thickness of the three different PVDF films used here were 28 μm (FDT1028K, Measurement Specialties), 52 μm (FDT1-052K, Measurement Specialties) and 220
μm (NDT1-220K, Measurement Specialties).



Pulse compressed US A-line signals were acquired with and without the acoustic lens,
placing the PVDF transducer (US source) at the object plane.



Pulse compressed US A-line signals were acquired with pre enhanced amplified chirp
signal to explore the possibility of bandwidth enhancement. To obtain the pre enhanced
chirp signal, the PVDF film transducer was driven with an amplitude boost function
which is the inverse of the combined frequency response of the PVDF film and the
transducer array.

151

7.6 Results
Comparison of SNR obtained after pulse compression with the SNR obtained with conventional
short pulse: US A-line signals obtained using the plane reflector as target are shown in Figure 7.2
to demonstrate the SNR enhancement due to pulse compression.

152

Figure 7.2: SNR enhancement as a result of pulse compression; (A) Short duration input pulse,
(B) Output signal recorded by the linear array when the input is A, here the presence of PVDF
film is visible but the signal due to the plane reflector is completely buried in noise, (C) Input
chirp signal having 40μs time duration and 8MHz sweep bandwidth, (D) Output signal when the
input is C (before pulse compression), here the presence of PVDF film is visible and the signal
due to plane reflector is barely visible, (E) Compressed pulse where the presence of both PVDF
film and the plane reflector are clearly visible. The input peak amplitude of both the short pulse
and the chirp signal were 0.25 volts. SNR for the plane reflector signal in E (SNRcompressed) is
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and the chirp signal were 0.25 volts. SNR for the plane reflector signal in E (SNR compressed) is
42.4, SNR for the plane reflector signal in D is 1.37 (SNRuncompressed) and SNR for the plane
reflector signal in B is 0.94 (SNRpulse). The signals marked as PVDF in B, D and E occurred due
to the plane wave emitted by the PVDF film transducer in the reverse direction (towards the
acoustic lens in Figure 7.1).
Comparison of SNR obtained after pulse compression with the SNR obtained with conventional
short pulse: Figure 7.3 shows the improvement of the SNR values after pulse compression.
GSNR or gain in SNR of the compressed pulse is the ratio of the SNRcompressed (SNR after
compression) to SNRuncompressed (SNR before compression). The SNR for an A-line signal was
calculated by taking the ratio of area under the power spectrum of signal to area under the power
spectrum of noise. The PVDF film transducer (Measurement Specialties, NDT1-220K) used here
consists of two layers of 110μm thick films and has 2.3 MHz 6dB bandwidth (1.7 MHz – 4
MHz). To obtain the compressed pulses, linear FM waves with 40μs time duration and 8 MHz
sweep bandwidth (0.5MHz – 8.5 MHz) were used. The conventional short pulse imaging was
done with short pulses having 3MHz center frequency. Figure 7.3 shows SNR of the compressed
pulse is much higher than that obtained with the conventional short pulse for the same input peak
voltages.
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Figure 7.3: Plot of SNR values obtained for the compressed pulse and the conventional short
pulse against peak input voltages.
Variation of GSNR/SNRcompressed with chirp signal bandwidth: Figure 7.4 shows the variation of
SNR values of the compressed pulse, obtained with a plane aluminum reflector as the target,
with the variation of time bandwidth product i.e. product of time duration (T0) and sweep
bandwidth (2B) of the input chirp signal. The PVDF film transducer (Measurement Specialties,
FDT1-028K) used here was 28μm thick. Though not measured, it was expected to have a
uniform spectrum over a wide frequency range because of its small thickness. Here the sweep
bandwidth of the input chirp was increased linearly maintaining the center frequency (fc) almost
the same. Both SNRcompressed and GSNR increase almost linearly with the increase of the time
bandwidth product. For time bandwidth product greater than 250, the GSNR remains constant
which may have happened due to the finite bandwidth of the receiving US transducer array
(12dB bandwidth: 3 MHz – 6.7 MHz). The SNR values obtained before and after pulse
compression for different input chirp signals have been listed in Table 7.1.
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Figure 7.4: Plot of GSNR and SNRcompressed for the compressed pulses against the time bandwidth
product of the input chirp signals.
Variation of Axial and Lateral resolution with chirp signal bandwidth: Table 7.1 lists axial and
lateral resolution of this imaging system as well as the SNR values obtained after pulse
compression with different input chirp signals. Figure 7.5A and 7.5B show the variation of axial
resolution (6dB width of the point spread function along Z [Figure 7.1] axis) and lateral
resolution (6 dB width of the point spread function along X [Figure 7.1] axis) with different
sweep bandwidth of the input chirp signal respectively. Figure 7.6 shows the two dimensional
point spread function in X-Z plane for a particular case in Table 7.1 and the corresponding axial
and lateral resolution. Axial and lateral resolutions for different chirp signals were measured
using the steel wire as the target. The PVDF film transducer (Measurement Specialties, FDT1028K) used here was 28μm thick.
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Table 7.1: Axial resolution, lateral resolution and SNR values before and after pulse compression
for different input chirp signals. The PVDF film transducer (Measurement Specialties, FDT1028K) used here was 28μm thick.

FM waves

Axial

Lateral

SNRuncompressed/

(Duration/Center

Resolution

Resolution SNRcompressed /GSNR

Frequency/Sweep

in mm

in mm

[Plane reflector target]

20μs/5MHz/4 MHz

0.56

1.2

1.63/46.7/28.64

25μs/5MHz/5MHz

0.51

1.2

2/95.71/47.77

30μs/5MHz/6MHz

0.49

1.3

1.67/269.46/162.48

35μs/5MHz/7MHz

0.44

1.3

1.9/464.39/243.83

40μs/4.5MHz/8MHz

0.45

1.3

1.99/518.54/260.21

Bandwidth)
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Figure 7.5: Plot of axial and lateral resolution against sweep bandwidth of the input chirp signal.
(A) Axial resolution vs sweep bandwidth (B) Lateral resolution vs sweep bandwidth.
Figure 7.5A shows that axial resolution improves almost linearly with the sweep bandwidth of
the input chirp signal up to a certain limit (7 MHz) and then it remains constant. The upper limit
of the axial resolution may have occurred due to the finite bandwidth of the receiving transducer
array. Figure 7.5B shows that lateral resolution remains almost constant with the variation of the
sweep bandwidth of the input chirp signals.
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Figure 7.6: Two dimensional point spread function of the imaging system after pulse
compression for an input chirp signal of sweep bandwidth 4 MHz and time duration 20μs; (A)
2D PSF (X-Z plane) displayed in purely logarithmic scale; (B) Lateral cut (along azimuthal/X
axis) of the 2D PSF in A, the 6dB width is 1.2 mm; (C) Axial cut (along Z axis/time axis) of the
2D PSF in A, 6dB width is 0.56 mm/0.36 µs.
To examine whether the acoustic lens would alter the quadratic phase relationship of the input
chirp signal, we performed pulse compression both in presence as well as in absence of the
acoustic lens. Here, we did not use any target. The acoustic lens was placed in between the
PVDF film and the transducer array in such a way that the lens was separated by equal distances
from both of the US transducers. The PVDF film was driven by amplified long duration chirp
signal [20 µs long and 4MHz sweep bandwidth] and the emitted US plane wave was received
directly by the transducer array. The compressed pulse was obtained by cross correlating the
input chirp used to drive the PVDF film and the output signal received by the transducer array.
The same experiment was repeated without the acoustic lens. The PVDF film transducer
(Measurement Specialties, FDT1-028K) used here was 28μm thick.
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Figure 7.7: Pulse compression in presence of the acoustic lens (A) input chirp signal of 20 µs
time duration and 4 MHz sweep bandwidth (B) output chirp signal received by the transducer
array (C) Phase spectrum of input and output chirp signals (D) Amplitude spectrum of the input
chirp (E) Amplitude spectrum of the output signal (F) Compressed pulse as a result of cross
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correlation between A and B.

Figure 7.8: Pulse compression in absence of the acoustic lens (A) input chirp signal of 20 µs time
duration and 4 MHz sweep bandwidth (B) output chirp signal received by the transducer array
(C) Phase spectrum of input and output chirp signals (D) Amplitude spectrum of the input chirp
(E) Amplitude spectrum of the output signal (F) Compressed pulse as a result of cross correlation
between A and B.
Figure 7.7 and Figure 7.8 show the results of the pulse compression experiments performed with
and without the acoustic lens in between the source and receiver transducer. For both the cases,
pulse compressions were successfully performed, as seen by the enhanced SNR and short time
durations of the compressed pulses. To examine whether the acoustic lens alters the phase
relationship of the chirp signals, the phase spectra of the input and the output chirp signal were
plotted for both the cases [Figure 7.7C and Figure 7.8C]. It is visible that, for both in presence
and in absence of the acoustic lens, within reasonable frequency range [2 MHz – 5 MHz, as seen
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from Figure 7.7D and Figure 7.8D] the output phase spectrum followed the input phase spectrum
without any major change. This proves conclusively that presence of the acoustic lens does not
alter the quadratic temporal phase of the linear FM signal during its passage through the lens.
The preliminary results show that a PVDF film transducer can be used as an US transmitter in
the acoustic lens focusing based US imaging system. This study demonstrates that the acoustic
lens does not alter the quadratic phase relationship of the chirp signal. Consequently the focused
chirp signal can be compressed into a short pulse with cross correlation processing. The SNR
enhancement due to pulse compression depends upon the time duration, swept bandwidth of the
input chirp signal and the frequency spectrum of the US transducers. Since two separate US
transducers have been used here as US source and receiver, significantly long duration chirp
signals can be utilized to achieve high GSNR values.
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7.7 Additional Results & Images
Table 7.2: Axial resolution, lateral resolution and SNR values before and after pulse compression
for different input chirp signals using 52 µm thick PVDF film transducer (FDT1-052K,
Measurement Specialties).

FM waves

Axial

Lateral

SNRuncompressed/

(Duration/Center

Resolution

Resolution SNRcompressed /GSNR

Frequency/Sweep

in mm

in mm

[With wire target]

20μs/5MHz/4 MHz

0.63

1.5

89/1018/11.43

25μs/5MHz/5MHz

0.61

1.5

102.45/1100/10.73

30μs/5MHz/6MHz

0.58

1.5

103.7/953/9.19

35μs/5MHz/7MHz

0.53

1.4

100/1927/19.27

40μs/4.5MHz/8MHz

0.51

1.6

118.5/940.4/7.94

50μs/5.5MHz/10MHz

0.50

1.5

60.56/261.7/4.32

Bandwidth)
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Table 7.3: Axial resolution, lateral resolution and SNR values before and after pulse compression
for different input chirp signals using 220 µm thick PVDF film transducer (NDT1-220K,
Measurement Specialties).

FM waves

Axial

Lateral

SNRuncompressed/

(Duration/Center

Resolution

Resolution

SNRcompressed

Frequency/Sweep

in mm

in mm

/GSNR

Bandwidth)

[With wire target]

20μs/5MHz/4 MHz

2.18

2.1

149/648/11.43/4.35

25μs/5MHz/5MHz

1.52

2.4

140/721/5.15

30μs/5MHz/6MHz

1.40

2.2

181/605/3.34

35μs/5MHz/7MHz

1.31

2.3

144.4/2793/19.34

40μs/4.5MHz/8MHz

1.32

2.3

241/2515/10.43

50μs/5.5MHz/10MHz

1.37

2.4

112.4/230.5/2.05
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Figure 7.9: Actual experimental set up [Block diagram shown in Figure 7.1] (A) Different
components in the water tank (B) The complete set up. The function generator generates the
signal which after being amplified by the power amplifier, is used to drive the PVDF film to
generate ultrasound wave. The backscattered ultrasound wave from the object as well as the part
of ultrasound wave generated by the PVDF film which moves in opposite direction than the
object are received by the 1D array through the acoustic lens and converted to a time dependent
voltage signal which is observed and saved in the oscilloscope.
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CHAPTER 8: Discussions, Conclusions & Future work
8.1 Discussions and Conclusions
8.1.1 PA Image Analysis
In this study, PA image analysis was performed retroactively on the ex vivo multiwavelength PA
images of excised human prostate and thyroid specimens. The aim of the study was to identify
malignant, benign and normal tissue using extracted features from the acquired PA images.
Special emphasis was given on differentiating malignant tissue from nonmalignant tissue. The
prostate specimens were obtained from patients who underwent biopsy confirmed prostatectomy
and the thyroid specimens were obtained from patients who underwent thyroidectomy because of
suspected thyroid lesion. Multiwavelength PA images were acquired immediately after surgery.
Histopathologists marked the ROIs corresponding to malignant, benign and normal on the
histology slides. Digital images of the histology slides were used as ground truth to select ROIs
in the 3D PA data.
Spatially varying chromophore concentration of tissue, extracted from multiwavelength PA
images, provides physiological information about the tissue. Measuring the concentration of
particular chromophores, specific tissue pathologies like malignancy can be identified. But the
inverse problem involving quantitative recovery of the chromophore concentrations from PA
images is extremely difficult due to factors like absorption and scattering of light inside tissue.
This makes tissue characterization, solely based on chromophore concentration, very difficult. In
this study, we decided to extract additional features, as many as possible, from the PA data and
then utilize the additional features along with extracted chromophore concentration for
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differentiation of malignant tissue from nonmalignant tissue. This way the additional features
would augment the capability of tissue characterization.
2D C scan PA image pixel values depend on the PA signal amplitude at a particular time instant
or summation/mean/maximum of the PA signal amplitudes acquired over a very small time gate.
Therefore, for the chromophore concentration estimation, the PA image signal at any particular
time instant or over a very short time gate is used. Neither chromophore concentration nor C
scan PA image pixel values directly depend on the temporal features of the RF PA signals. The
temporal features of the time dependent PA signal depend on the shape and size of the particular
PA absorbers. Evidence for this has been demonstrated via simulation in Chapter 5. We
hypothesized that between malignant and nonmalignant tissues, PA absorbers i.e. the sites of PA
wave generation, differ in shape and size and these differences will be manifested in the temporal
features of the RF PA signals. As the spectrum and time domain features of the RF PA signal are
correlated, analysis of PA spectrum can potentially give useful information about the structural
change of PA absorbers between different tissue pathologies. We decided to analyze the
spectrum of time dependent PA signals belonging to different tissue pathologies. To obtain a
clear idea about the distinctive temporal features and frequency content of PA signal generated
by different shaped PA absorbers, we modeled PA signals due to spherical, cylindrical and thin
film shaped absorbers. We extracted a number of features from ROIs of importance, selected
from the acquired 3D PA data of the excised human prostate and thyroid specimens. For
selecting the ROIs, digital images of the marked histology images were used as ground truths.
The extracted feature can be divided broadly into three different categories namely a)
multiwavelength PA pixels [PA pixels at 760 nm, 800 nm, 850 nm, 930 nm and 970nm] b)
chromophore concentrations [deoxyhemoglobin, oxyhemoglobin, lipid and water] and c)
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frequency parameters [slope, midband fit, intercept and spectral centroid at 760 nm, 800 nm, 850
nm, 930 nm and 970 nm]. Prior to extraction of the frequency parameters, we did an extensive
simulation study to find out the limitations and applicability of the frequency analysis technique
for our limited bandwidth PA acquisition system. Once the parameters/features were extracted,
statistical analysis was performed to find out whether they are significantly different between
different tissue pathologies. Here, as differentiation of malignant tissue from nonmalignant tissue
was the primary objective of this study, a new tissue category ‗nonmalignant‘ was introduced in
which benign and normal tissue data were stacked together. For prostate tissue, only 5 [PA pixel
value at 930 nm, water concentration, slope at 930 nm and spectral centroid at 930 nm and 970
nm] out of a total of 29 features were not significantly different between malignant and
nonmalignant tissue, whereas for thyroid the number of parameters which were not significantly
different between malignant and nonmalignant tissue was also 5 [slope at 760 nm, 800 nm, 850
nm, 930 nm and 970 nm]. Between malignant and normal tissue the number of parameters not
significantly different was 5 [PA pixel value at 930 nm, water concentration, slope at 930 nm and
970 nm, spectral centroid at 970 nm] for prostate tissue and 4 [slope at 760 nm, 850 nm, 930 nm
and 970 nm] for thyroid tissue. For malignant vs. benign tissue, 8 [PA pixel value at 800 nm,
oxyhemoglobin and lipid concentration, slope at 800 nm, intercept at 760 nm and 970 nm,
spectral centroid at 800 nm and 850 nm] out of 29 parameters were not significantly different for
prostate tissue and 8 [oxyhemoglobin, lipid and water concentration, slope at 800 nm, 850 nm,
930 nm and 970 nm, spectral centroid at 760 nm] out of 29 parameters were not significantly
different for thyroid tissue. As far as benign vs. normal tissue is concerned, for prostate 7 [water
concentration, slope at 760 nm, 850 nm, 930 nm and 970 nm, intercept at 930 nm, spectral
centroid at 800 nm] out of 29 parameters were not significantly different while for thyroid the
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number of parameters not significant different were also 7 [PA pixel value at 970 nm, slope at
970 nm, midband fit at 970 nm, intercept at 760 nm, 800 nm and 970 nm, spectral centroid at
970 nm].
Multidimensional dataset were built with the extracted features from prostate PA data and
classification algorithms were applied on them to predict malignant and nonmalignant prostate
tissue. The process in which classification algorithms like ANN, SVM etc. are employed for
detection and diagnosis of the suspected disease is known as CAD. As classification algorithms
can process a large number of markers simultaneously and they can model non-linear
relationship between inputs and outputs, the limited decision making abilities of human beings
can be improved by CAD. In this study, using SVM and ANN, the ability of the extracted
features to predict malignant and nonmalignant prostate accurately was tested. ANN with a
particular architecture, which was found to produce the best prediction of malignant as well as
nonmalignant prostate tissue using the complete 29 dimensional feature space, was used to
compare the performance of features belonging to different categories. Frequency parameters i.e.
parameters extracted from PA spectrum, performed best in differentiating malignant from
nonmalignant tissue [sensitivity and specificity with testing dataset are 85% and 84%].
Performance of combination of all the features [29 dimensional feature space] was better than the
performance of the frequency parameters alone [sensitivity and specificity with testing dataset
are 93% and 91%].
This study shows that parameters extracted from PA spectrum are significantly different between
malignant and nonmalignant tissue type for human prostate and thyroid tissue. From the results
of this study it is evident that the frequency parameters alone can be used in a suitable CAD
algorithm to differentiate malignant and nonmalignant prostate tissue with high accuracy. The
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study has also shown that when parameters belonging to all the categories used together, the
accuracy of the malignant prostate tissue prediction become highest.
As mentioned in Chapter 1 [Section 1.2], this study has intended to fill specific gaps in the field
of PA imaging for cancer detection. Those specific gaps have been filled in the following manner


A large scale study, in which frequency domain parameters extracted from ex vivo
multiwavelength PA image data was used to differentiate between malignant, benign and
normal tissue, was performed involving 30 prostate cancer patients and 20 thyroid cancer
patients.



Time domain and frequency domain PA features were combined to form a
multidimensional feature space which was applied to a suitable CAD system for prostate
cancer diagnosis.



Using the same CAD system, performances of time domain PA features were compared
with that of frequency domain PA features for prostate cancer diagnosis.

8.1.2 Pulse echo US Imaging System
PA imaging does not provide the required anatomical cues to localize the position of the detected
lesion. For image guided diagnostic and therapeutic procedures, accurate localization of the
detected lesion is of utmost important. For example, in image guided needle biopsy for prostate
cancer diagnosis, accurate positioning of the malignant tumor is not only essential for directed
sampling but it is also very important for providing positional feedback of the needle tip relative
to the lesion, based on which the needle tip coordinates can be corrected in real time. Although
sensitivity and specificity of US imaging for diagnosis of prostate cancer lesions is low, it can
provide major anatomical cues like organ boundary, presence of other major organs etc. Using
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coregistered PA and US image, it is possible to detect as well as localize cancer lesions with high
accuracy. In this study, we developed a novel pulse echo US imaging system which is
compatible with our existing PA imaging system. As we incorporated acoustic lens based
focusing in our US imaging system, a separate US source and receiver were needed to be used
here. Keeping in mind that the US imaging system would be integrated with our existing PA
imaging system in the future, we chose the US source in such a way that its interference to the
PA and US wave coming out of the soft tissue, would be minimal. A PVDF film transducer,
because of its flexibility, low acoustic impedance mismatch with water and small thickness, was
chosen as the US source. As PVDF film does not transmit high intensity US wave, the SNR of
the received US wave was anticipated to be low. To improve the SNR, pulse compression
technique was implemented in this system. We verified that the pulse compression technique can
be implemented in presence of the acoustic lens. SNR enhancement due to pulse compression
was observed. We measured the 2D PSF of the imaging system in a water bath. As the receiver
transducer array used in this imaging system is similar to that used in the PA imaging system
along with the similar acoustic lens focusing based technology, we expect that this US imaging
technology can be easily incorporated to our existing PA imaging probe.
The results of this study show that PVDF film can be successfully used as US transmitter and
pulse compression technique, even in presence of acoustic lens, can be used to enhance SNR of
the backscattered US signals.
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8.2 Future Works
8.2.1 PA Image Analysis:
For quantitative feature extraction like absolute optical absorption coefficient recovery or
chromophore concentration recovery, optical absorption and scattering inside the soft tissue and
their nonlinear relationship with laser fluence distribution in the soft tissue has to be considered
in detail. In this study, we worked with ex vivo PA images of thin [2 – 3 mm] tissue specimens
and we hypothesized that the laser light fluence will not vary in XY plane severely because of
small tissue thickness. We incorporated 1D light attenuation model to correct for the light
attenuation effect only along Z axis, considering that the optical properties of specimens remain
the same along the depth. For in vivo mage analysis or ex vivo imaging with thick tissue
specimens, a detailed 3D model based or experimental observation based correction scheme for
optical attenuation should be incorporated. There is no standardized correction scheme that can
be applied to all the PA imaging configurations. Still, prior to doing any quantitative analysis
with in vivo PA images, a detailed 2D/3D correction scheme, that will be appropriate for the
particular PA imaging configuration, should be implemented. Although the number of
features/parameters, extracted from multiwavelength PA data of the excised human specimens
was quite high, a few different approaches can be undertaken to extract some additional number
of features. For example, selecting a suitable mother wavelet, continuous wavelet transform
(CWT) of the PA signals can be computed and then wavelet coefficients corresponding to
instantaneous peak frequency and time can be extracted corresponding to ROIs belonging to
different tissue pathologies. Registration for ROI selection in the 3D PA data can be made
automatic for increasing the ROI selection accuracy. The automatic registration process has to be
a two-step process [registration between digital photograph of the tissue specimen and the digital
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marked histology slide followed by registration between the digital specimen image and the 2D
C-scan PA image] and in developing it, all the difficulties mentioned in chapter 3 have to be
considered.
8.2.2 US imaging system
The immediate future work with the US imaging system is to incorporate the US imaging
technology in the existing PA imaging probe and test the performance of the dual mode imaging
probe with phantoms and soft tissue specimens. This includes experiments with specially
designed phantoms to test how well the PA and US images acquired by the dual mode probe are
registered. Once the SNR of US images and registration between US and PA images are
satisfactory, additional measures/modifications can be implemented to enhance the performance
of US imaging. Axial resolution improvement and side lobe reduction are two important
performance enhancement factors to consider. Hardware realization of post processing works
related to pulse compression technique is another important factor to consider seriously as the
near real time imaging capability of the dual mode imaging probe depends on it.
8.3 Impact
The image analysis framework developed in this study has shown that multiple features can be
extracted from multiwavelength 3D PA data generated by soft tissue and the features can be used
in a suitable CAD system for effective diagnosis of malignant tissue. Incorporating a suitable
correction scheme for wavelength dependent, nonlinear distribution of light fluence inside soft
tissue, this image analysis framework can also be applied to multiwavelength PA images
acquired in vivo. This technology is not limited to any specific organ or disease or PA imaging
configuration. Irrespective of the organ, be it breast, prostate, skin, thyroid or anything else and
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disease, be it cancer, coronary artery blockage or anything else and the PA image configuration
be it PAT or PAM, as long as 3D PA data can be acquired, this image analysis technology can be
applied to the data. Exogenous contrast agent based PA imaging is becoming increasing popular.
This image analysis technology can be potentially used to augment the abnormality detection
capability of contrast agent based PA imaging. As it is a post processing technology, it does not
require any new hardware and the required software can be built using any of the widely
available packages like Matlab, C++ or Python.
As mentioned in Chapter 2, imaging technology with high sensitivity and specificity is required
for accurate prostate cancer diagnosis and management. Although the number of patients
considered for this study is small and this was an ex vivo study, the results of this study are
promising. This may inspires researchers to undertake large scale in vivo PA imaging of prostate
cancer with CAD system.
This study has found that the parameters extracted from the frequency domain of PA signals can
play a significant role in tissue characterization. Power spectrum analysis, which is a proven
technology for tissue characterization in US imaging, is not a well researched domain in the case
of PA imaging. For example, no one has tried to find out if analytical relations exist between the
spectral parameters and the shape and size of PA microabsorbers. Findings of this study may
inspire researchers to undertake further studies for acquiring a better understanding of the power
spectral parameters extracted from PA signals.
The dual mode imaging system, that can be developed by incorporating the novel US imaging
technology developed in this study into the existing ex vivo PA imaging probe, will be able to
acquire coregistered PA and US images of the soft tissue in near real time. Although the existing
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PA imaging probe is an ex vivo imaging probe, it has been designed in such a way that after
incorporating a proper laser light delivery system, it can be used as in vivo transrectal PA and US
imaging probe for prostate imaging. The US imaging technology has been developed in such a
way that it can be incorporated in the in vivo imaging probe. The dual mode PA and US imaging
probe will potentially detect as well as localize malignant tissue with high accuracy. In addition
to prostate cancer imaging, the dual mode imaging probe can also be used for in vivo PA
imaging of breast, thyroid and skin. The US imaging technology developed in this study has
successfully used PVDF film as US transmitter and implemented pulse compression technique
for SNR enhancement of the received US signals.
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APPENDICES: ADDITIONAL WORKS
A.1 Cepstrum Simulation
From 1D time dependent PA signal simulations [Chapter 5], it has been observed that the PA
spectra generated by different PA absorbers contain periodic/quasiperiodic structures. As the PA
frequency spectra depend on the shape and size of PA absorbers, we assumed that quantitative
information about the dimension of the PA absorber could be extracted from the
periodic/quasiperiodic structure of the PA absorbers. In Chapter 5, we fitted linear models to the
PA power spectrum within usable bandwidth to extract information from PA spectra. Here, we
thought of applying cepstrum analysis to characterize the periodicity of the PA spectra and
thereby getting information about the size of the PA absorber. In addition to the inherent periodic
nature of the PA spectra, presence of more than one PA absorbers along the depth inside a ROI
give rise the high requency ripple in the resultant frequency spectrum of the PA A-line signal.
This high frequency ripple can also be characterized by cepstrum analysis to find out the distance
between the successive absorbers along the depth. Using a phantom study, Gertsch et al.
experimentally demonstrated that diameter of single cylindrical absorber can be determined from
the quefrency corresponding to the cepstrum peak of the PA signal generated by the absorber
[A.1]. Here, we performed a simulation study to observe the relationship between the cepstral
peaks and the dimensions of different PA absorbers.
If a time dependent signal z(t) can be expressed as convolution of x(t), the basic wavelet and e(t)
a high frequency time dependent signal, then cepstral analysis can be used to express z(t) as the
sum of two signals.
z(t )  e(t )  x(t )  zˆ(t )  eˆ(t )  xˆ(t )

A.1
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The Cepstrum of a data sequence is obtained by taking the IDFT (inverse discrete Fourier
transform) of the logarithm of the magnitude of the DFT (discrete Fourier transform) of the data
sequence. Figure A.1 describes the three steps involved in calculating the cepstrum of a data
sequence.

Figure A.1 Cepstrum Analysis
If, Z(n), E(n) and X(n) be the Fourier transforms of z(t), e(t) and x(t), then
Z (n)  E (n) X (n)

A.2

Taking logarithm of the magnitude of the Fourier transforms, we get

log Z (n)   log E (n)   log X (n) 

A.3

Now, if the IDFT is taken of both sides of equation A.3, then
zˆ(t )  eˆ(t )  xˆ (t )

A.4

Where zˆ(t )  IDFT [log( Z (n) )] , eˆ(t )  IDFT [log( E (n) )] and xˆ (t )  IDFT [log( X (n) )]
The logarithm of the spectrum of z(t) can be imagined as a waveform with some form of
amplitude modulation. Here, the logarithmic amplitudes of the ripple introduced by e(t), will be
modulated by log(X(n)). These two components can be separated by taking the inverse Fourier
transform, as shown in Equation A.4. After taking the inverse Fourier transform, the signal will
be transformed into time domain, but since the logarithm of the spectrum in Equation A.3 has
been treated as a waveform, so the independent variable in Equation A.4 will be considered as a
quantity similar to frequency. To differentiate it with the actual frequency, it has been named as
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‗quefrency‘ and the signal obtained in Equation A.4 is named as ‗cepstrum‘. The cepstrum will
contain a large peak due to the ripple and some other peaks due to the amplitude modulation i.e.
the basic wavelet. Now, if the ripple and the basic wavelet occupy different quefrency ranges,
then they can be separately retrieved by ‗liftering‘ in the quefrency domain which is equivalent
to filtering n the frequency domain [A.2, A.3].

Figure A.2: Simulated PA amplitude spectrum and cepstrum for spherical PA absorber (A)
Normalized amplitude spectrum generated by a spherical PA absorber of radius 0.5 mm (B)
Logarithm of PA amplitude spectrum in Figure A.2A (B) Cepstrum plot of the PA signal
generated by a spherical PA absorber of radius 0.5mm (D) Normalized amplitude spectrum
generated by two spherical PA absorbers separated by 7 mm along depth/Z axis and each of
radius 0.5 mm (E) Logarithm of PA amplitude spectrum in Figure A.2D (F) Cepstrum plot of PA
signal generated by two spherical PA absorbers separated by 7 mm along depth/Z axis and each
of radius 0.5 mm.
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Figure A.2 shows the simulated amplitude spectrum and cepstrum plots of the PA signal
generated by spherical absorbers. While the upper column [Figure A.2A-C] shows spectrum and
cepstrum due to a single PA absorber, the lower column show similar plots for PA signal
generated by two identical spherical PA absorbers arranged along Z axis at a distance 0.7 mm
from each other. The solid black arrow in Figure A.2C shows the primary cepstral peak
corresponding to the radius of the PA absorber. As it can be seen from Figure A.2A and also
from Equation 5.16, the minima in the PA amplitude spectrum are not exactly periodic. We
assume that is the reason why the primary cespstral peak at quefrency 0.69 µs in Figure A.2C
does not exactly correspond to the theoretical location of the cepstral peak [0.64 µs]
corresponding to the radius of the sphere. In case of two similar PA absorbers separated by a
certain distance along Z axis, high frequency ripples appear in the PA amplitude spectrum as
seen in Figure A.1D. These ripples manifest a secondary cepstral peak indicated by the broken
arrow in Figure A.2E. The quefrency corresponding to the secondary cepstral peak is 4.543 µs
while theoretically it should appear at 4.48 µs.
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Figure A.3: Simulated PA amplitude spectrum and cepstrum for cylindrical PA absorber (A)
Normalized amplitude spectrum generated by a cylindrical PA absorber of radius 0.5 mm (B)
Logarithm of PA amplitude spectrum in Figure A.3A (B) Cepstrum plot of the PA signal
generated by a cylindrical PA absorber of radius 0.5mm (D) Normalized amplitude spectrum
generated by two cylindrical PA absorbers separated by 7 mm along depth/Z axis and each of
radius 0.5 mm (E) Logarithm of PA amplitude spectrum in Figure A.3D (F) Cepstrum plot of PA
signal generated by two cylindrical PA absorbers separated by 7 mm along depth/Z axis and each
of radius 0.5 mm.
Figure A.3 shows the simulated amplitude spectrum and cepstrum plots of the PA signal
generated by cylindrical absorbers. While the upper column [Figure A.3A-C] shows spectrum
and cepstrum due to a single PA absorber, the lower column show similar plots for PA signal
generated by two identical cylindrical PA absorbers arranged along Z axis at a distance 0.7 mm
from each other. The solid black arrow in Figure A.3C shows the cepstral peak corresponding to
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the radius of the PA absorber. The quefrency corresponding to the cepstral peak indicated by the
arrow in Figure A.3C is 0.67 µs. In case of two similar PA absorbers separated by a certain
distance along Z axis, high frequency ripples appear in the PA amplitude spectrum as seen in
Figure A.3D. These ripples manifest a secondary cepstral peak indicated by the broken arrow in
Figure A.3E. The quefrency corresponding to the secondary cepstral peak is 4.527 µs.

Figure A.4: Simulated PA amplitude spectrum and cepstrum for a thin film PA absorber (A)
Normalized amplitude spectrum generated by a thin film PA absorber of thickness 0.5 mm (B)
Logarithm of PA amplitude spectrum in Figure A.4A (B) Cepstrum plot of the PA signal
generated by a thin film PA absorber of thickness 0.5mm
Figure A.4 shows the simulated amplitude spectrum and cepstrum plots of the PA signal
generated by cylindrical absorbers. The solid black arrow in Figure A.4C shows the primary
cepstral peak corresponding to the thickness of the thin film PA absorber. The quefrency
corresponding to the cepstral peak indicated by the arrow in Figure A.4C is 0.37 µs.
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A.2 Photoacoustic Microscopy System
A Photoacoustic Microscopy [PAM] system has been developed in our laboratory to acquire
high resolution PA image data generated by small and thin tissue samples.

Figure A.5: Block diagram of the PAM system.
Figure A.5 shows the block diagram of the PAM setup developed in our laboratory. Fiber optic
cable or fiber bundle delivers pulse laser light from the Q-switched Nd-YAG laser (Wavelength:
1064 nm, Pulse Repetition Frequency: 10 Hz, LPU 250, Litron Laser) on the sample held by the
sample holder. PA waves generated by the sample after absorbing laser light, are collected by a
single element high frequency focused transducer. The transducer is connected to one of the
eight channels of the variable gain preamplifier (Texas Instruments VCA8500EVM). The
VCA8500 board is capable of producing a maximum gain of 50 dB (20 dB pre amplification
gain combined with a selectable post gain amplification of 20/25/27/30 dB) along with a choice
of 10 MHz or 15 MHz low pass filtering. The preamplifier is connected to the digitizer which
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contains an eight channel National Instruments (NI) PXI-5105 high speed digitizer in a NI PXI1033 chassis. After firing each pulse, the laser provides an output trigger signal to the PXI
chassis for synchronization between the laser and DAQ system. The sampling frequency of the
digitizer is 60 MHz with 12 bit resolution. The PXI-5105 provides a 16 MB onboard memory
buffer in which the digitized PA signals are stored temporarily. The PXI chassis containing the
digitizer is connected to the computer where the digitized PA signals are transferred via MXI
interface. The sample holder is held by an assembly of two translational stages (Zaber
Technologies Inc.) which are controlled by two linear actuators (Zaber Technologies Inc.). The
translational stages move the sample holder along X and Y axis to enable the raster scanning of
the sample by the stationery transducer element in the cross sectional plane. The complete data
acquisition and the scanning procedure is controlled by a Labview based software [A.4]. The
stored PA signal values are processed by a custom designed Matlab based software for
generating corresponding C scan and B scan PA images. For this setup, the lateral resolution of
the PA image depends on the focused beam diameter of the single element transducer. For
improving lateral as well as axial resolution, a high frequency focused transducer (50 MHz
V3320/30 MHz V376SU/20 MHz V317/15 MHz V313, Panametrics, Olympus) is used here.
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Figure A.6 shows the actual experimental setup for the PAM system.

Figure A.6: Experimental setup of the PAM system.
A.3: Modeling of Light Distribution in Soft Tissue
For quantitative PA imaging, implementation of a suitable correction scheme for excessive light
attenuation inside soft tissue is of utmost importance. The ideal correction scheme should be
based solely upon experimental observation of light distribution inside soft tissue. As that would
require dedicated hardware along with excessive time, researchers often try to build correction
schemes based on 2D/3D models for light transport inside soft tissue. Here we modeled pulse
laser light distribution inside excised prostate tissue using Monte Carlo method. Values of the
optical properties of the excised prostate tissue were collected from the available literature [A.5].
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A.3.1 Monte Carlo Modeling
Monte Carlo method consists of a stochastic model in which the value of a physical quantity is
determined by computing the average of the independent samples of a certain random variable.
The independent samples of the random variable are chosen randomly from the probability
distribution of the variable [A.6]. We used MCML along with CONV, standard C language
based tools developed by Wang et al. [A.7, A.8] for modeling steady state light transport through
multi layered tissue using Monte Carlo method for simulating laser light distribution inside
excise prostate tissue.

Figure A.7: Absorbed laser light energy distribution inside excised prostate tissue (A) Absorbed
laser energy in a RZ plane in dB scale (B) Absorbed laser energy in J/cm3 at different values of Z
for R = 0 (C) Absorbed laser energy vs. R for Z = 0.5 cm.
Figure A.7 shows the absorbed laser energy distribution inside an excised prostate tissue
specimen.
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Figure A.8: Laser light Fluence distribution inside excised prostate tissue (A) Laser Fluence in a
RZ plane in dB scale (B) Laser Fluence in J/cm2 at different values of Z for R = 0 (C) Laser
Fluence vs. R for Z = 0.5 cm.
Figure A.8 shows the laser fluence distribution inside an excised prostate tissue specimen. Both
absorbance and fluence were modeled modeled using MCML and CONV.
For generating absorbance as well as the fluence plots, the following parameter values were
used.
µa = 0.6 cm-1, µs = 100 cm-1, g = 0.94. [Optical properties of excised normal human prostate
tissue at 850 nm]
The incident pulse laser beam had Gaussian intensity profile, 0.5 cm beam width and 20 mJ per
pulse input energy.
Total number of photons used for MCML modeling = 10,000.
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